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FOREWORD


This report summarizes the results of a cardiovascular per­

formance monitoring instrumentation investigation. It contains


the results of our investigation of numerous techniques and in­

struments applicable to the space-flight cardiovascular decon­

ditioning problem.
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INTRODUCTION


Future manned space missions can be planned and executed only


if the conditions assuring man's well-being and effectiveness are:


defined. Furthermore, the selection of instrumentation for


space-flight physiological experiments must be a function of a


specific set of criteria. The Apollo and Skylab iissions demon­

strated-that changes do take place in the major physiological


systems of the body during space flight and that an accurate time. 
profile of tbese changes, as a fuiction of weightlesshess, is re 
quired to determine the true nature of these biological alte'­
ations. 
This report summarizes the historical space-flight observa­

tions, discusses applicable instrumentation, and provides recQm­

mendations for future research and development activity required


for cardiovascular deconditioning monitoring.
 

The following assumptions made in the performance of this


study stimulated enthusiastic and significant response from the


biomedical community at large: .


1) 	 More sophisticated biomedical instrumentatioh may p6ssibly


be flown than in previous space flight missions;


2) -Extensive bed-rest studies will be conducted;­

3) 	 Human surrogates will be flown in unique animal-hd1ding


facilities;


if - t 
4) 	 The Space Shuttle flight potential for biomedical mission


specialists is high;


5) 	 Significantly greater European participation is planned;


6) 	 Broad biomeaical science community participation is "esen­

tial.


The objectives for establishing a rationale for cardiovascular


performance assessment were best described by Dr. E. McCutcheon,
 

NASA-ARC, in table I.


This study is primarily concerned with the observation mech­

anisms dealing with pressure, flow, morphology, temperature etc.


The approach -takenin the performance of this study was to (1)


review ground and space-flight data on cardiovascular function,


including earlier related ground-based and space-flight animal


studies, Mercury, Gemini, Apollo, Skylab, and recent bed-rest


studies, (2) review cardiovascular measurement parameters re­

quired to assess individual performance and physiological


TABLE I.- CARDIOVASCULAR DECONDITIONING PROBLEM


Passenger Selection Criteria and Indices


What restrictions,must be plaied on passenger candidates for


fTight?


Which indices will identify susceptible individuals and guide de­

cisions on exclusion or protective measures?


Fundamental Mechanisms


What causes the changes identified as cardiovascular decondi­

tioning?


What are the critical variables?


Safety Monitoring


What are the tolerance limits; what physiological penalties are


imposed by the deconditioning-induced loss of physiological


reserve?


Which tests should be performed and which variables should be


monitored9


Protection: Prevention/Countermeasures


Which techniques are most effective?


Which technique or combination is most practical?


aliterations during space flight, (3) perform an instrumentation


survey including a literature search as well as personal contact


with the applicable investigators, (4) assess instrumentation ap­

plicability with respect to the established criteria, and (5)


recommend future research and development activity.


It is concluded that, for the most part, the required instru­

mentation technology is available but that mission-peculiar cri­

teria will require modifications to adapt the applicable instru­

mentation to a space-flight configuration.
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OBSERVATIONS/FUNCTIONS


The cardiovascular system basically consists of the vascular 
system, the blood and blood volume and its control and regulation, 
and the heart and the control and regulation of its output. Since 
it is not the intent of this report to provide a dissertation on 
cardiovascular physiology, the reader is referred to Rushmer 
(1972) for further informatiom on structure and function. . 
To obtain a level of knowledge of the cardiovascular system


and the effects on it of space-flight stresses that will permit


long-duration manned missions to be planned with assurance, a


systematic program of ground-based and inflight experimentation


and testing using atraumatic noninvasive techniques on humans is


essential. A program is also required that will include comple­

mentary experiments with animals in which chronically implanted,


telemetered data sources are emphasized. Due to time-line and


scheduling constraints, it is essential that as much ground test­

ing as practical be conducted and flight experiments be limited


to those requiring zero-g and other space-flight conditions not


possible to simulate. To accomplish this, a particular set of


instrumentation and techniques for biomedical measurements and


monitoring is essential and is discussed herein.


Before proceeding, it is significant to note that a rather


thorough dissertation on the physiological problems of manned


space flight can be found in a report of a study conducted in


1966 by the Space Science Board of the National Academy of


Sciences National Research Council, Publication 1485A, Volume I,


"Circulation."


This report contains extensive discussions of (1) control and


regulation of the vascular function, (2) control and regulation


of organ circulation, (3) control and regulation of blood volume


and cardiac output, and (4) stress factors in manned space flight.


Based on the results of previous space-flight and bed-rest


studies and on discussions with the medical personnel at the


respective NASA centers, it was concluded that the assessment of


cardiovascular deconditioning due to weightlessness during space


flight would include the following primary observations:


1) Fluid distribution changes and vascular compliance;


2) Increased loading of the heart;


3) Instability of cardiac electrical activity;


4) Modifications of cardiovascular regulation pattern;
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5) 	 Blood volume shifts during dynamic states such as re­
entry and postflight one-g conditions; 
6) 	 Postflight orthostatic tolerance due to space flight; 
7) 	 Thermal stress effects;


8) 	 Isolation stress effects;


9) 	 Circadian rhythm effects;


10) Cellular alterations.


Tables II and III were therefore assembled to provide a can­

didate set of observations for cardiovascular deconditioning


assessment for man and for human surrogates.


Based on these measurements, candidate sensors were investi­

gated and are discussed in the Instrumentation section of this


report. Obvious instrumentation such as a centrifuge blood sample


processor and freezer for obtaining and storing blood plasma were


not included in this report but are included in the listing of


CORE equipment in the appendix.
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TABLE II.- HUMAN STUDIES


Measure blood pressure - Systolic/diastolic


Determine venous capacitance


Determine arterial flow in limbs


Determine renal blood flow


Acquire blood samples and separate plasma


Collect urine daily and measure volume


Determine body fluid compartment volumes
 

Determine heart chamber volumes
 

Record ECG/VCG/pulse
 

Derive stroke volume


Derive cardiac output
 

Perform environmental monitoring


Perform biochemical analyses


Measure pulmonary capillary blood volume and flow


TABLE III.- HUMAN SURROGATE STUDIES


Record chamber pressures


Determine chamber volumes


Derive ventricular compliance


Perform intercardiac catheterization
 

Measure organ blood flow


Record ECG/VCG/pulse


Derive stroke volume


Derive cardiac output


Collect blood samples and separate plasma


Collect urine daily and measure volume


Derive body fluid compartment volumes
 

Record food and fluid intake


Have provisions for histological and biopsy procedures


Perform biochemical analysis


Perform environmental monitoring
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As pointed out previously, many of the measurements and ob­

servations in tables II and III resulted from discussions with


individuals from the biomedical community. Typical suggested


protocols are tabulated.


R. Whittingham, MD, Response to cardiopulmonary stress testing 
RAF at NASA-JSC Observation of cardiovascular control mechanisms


Observation of fluid volumes, flow, and distribu­

tion of extracellular, interstitial, and inter­

cellular fluids


Vascular observations of central, peripheral, and


microcirculation


S, A. Bergman, 1D, Measurement of fluid shift and interthoracic


NASA-JSC blood volume


Observation of pulmonary and lung compliance 
Measurement of leg circumferences 
Drug infusion experiments with primates


Dimensional measurements of the heart 
Injection of microspheres into primates 
Cerebral flow measurements for analysis of motion 
sickness and head fullness 
D. Otianley, PhD, ultrastructure analysis of cellular structures 
JPL resulting from cardiovascular deconditioning


Analysis of vascular permeability effected by 
space flight
 

WenKo, MD, PhD, Muscle stimulation esperiments for primates


Case Western Reserve Increase heart rate and blood pressure and observe


University, Cleveland effects


Electrically stimulate the vagal nerve 
Study control mechanisms of heart 
Position electrodes on ventricle, stimulate heart, 
and oberva changes 
David Flemoing, Md, Exgometer-type centrifugal exerciser to be used


PhD, Case Western as a gravity simulator and for stress testing


Reserve


G. W. Roffler, MD, Monitoring of invasive parameters using chron­

NASA-JSC ically instrumented animals


Development of an ultrasonic system for Shuttle 
Craig J. Hartley, PhD, and Henry G. Hanley, MD, Baylor re­

searchers at Methodist Hospital in Houston, have been involved in


physiological and pharmacological animal studies for a number of


years and have developed a system for chronically instrumenting


healthy animals and studying the effects of experimental cardio­

active drugs on them. This system consists of a multichannel


pulsed Doppler flowmeter system for the simultaneous measure­

ment of regional blood flow to several tissues, Konigsberg pres­

sure gages, and a multichannel ultrasonic segment-length monitor


for measuring regional myocardial dimensions. Their current


capability enables simultaneous monitoring of four regional blood


flows, three regional myocardial dimensions, and arterial and 
left ventricular pressure.


The many more suggestions received from the biomedical com­

munity are too extensive to list. Nevertheless, all inputs were


considered and used in the development of the candidate observa­

tions and functional analyses summarized in tables II and III. 
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HISTORICAL REVIEW OF CARDIOVASCULAR PERFORMANCE MONITORING


During this study, the cardiovascular experiments performed


in the Mercury, Gemini, Apollo, Skylab, and ground-based studies,


i.e., Skylab medical experiments altitude test (SMEAT) and bed­

rest studies, have been summarized in terms of mission constraints,


experiment objectives, instrumentation, and results.


Mercury Flight


The Mercury flight program consisted of six manned flights


and four human surrogate flights. The pilots of the Mercury


flights all withstood the stresses of preflight, flight, and


postflight phases with no evidence of degradation. One symptom
 

of the pilot's functional integrity, or the static hypertension


accompanied by accelerated pulse response, was exhibited in post­

flight examination. This condition returned to normal while the


pilot was sleepting 9 to 12 hours after landing.


The specific results, experiments, and instrumentation of the


MA-9 mission are presented for Astronaut L. Gordon Cooper, Jr.


and are exemplary for the Mercury project.


Preflight observations.- Medical examinations of Astronaut


Cooper were conducted both before and after six preflight space­

craft checkout tests and a session in the Cape Kennedy procedures
 

trainer, all of which required the pilot to wear the full pres­

sure space suit. Also, special examinations to assess the pilot's


fitness for flight were conducted 11 and 3 days before launch.


A final examination was performed by the NASA flight surgeon on


launch morning. The examination included measurement of heart


rate via electrocardiogram R-waves and blood pressure. The pre­

flight data were collected to establish the baseline physiological
 

response of the MA-9 astronaut specifically using the flight bio­

medical instrumentation. This consisted of two sets of ECG leads


and a blood pressure measuring system (BPMS). The latter was


made up of a microphone, pressure cuff, and automatic controller.


The ECG from the preflight observation period was scanned re­

peatedly. The collective opinion of numerous observers of the ECG


was that marked normal sinus arrhythmia was present with frequent


occurrences of a wandering cardiac pacemaker. At times, sinus


node suppression was sufficient to allow activation by the atrio­

ventricular (A-V) node with escape and fusion beats. This and


other variants were considered acceptable for this individual on


the basis of extensive preflight testing.


REPRODUCBILITY OF THE 
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The flight data are summarized in tables IV and V along with 
preflight and postflight data. No significant anomalies were 
noted during flight.


TABLE IV.- SUMMARY OF HEART RATE DATA


Preflight


Overall Range of Range of ±2


standard

Duration of Mean 
 mean rates deviations


Date Procedure observation,


hr:min Heart rate, Heart rate, Heart rate,


beats/min beats/min beats/min


September 1951 Centrifuge 56:23 72 62 to 83 39 to 104


to May 15, simulations


1963 and checkout


procedures


Inflight


Range Respiration 
Mean Heart Rate of Mean 
Duration Heart i2 standard Range, Number 
of obser­ rate, deviations, beats/ of values 
Date Procedure vation, 
hr: man 
beats/ 
min 
beats/min min 
May 15 and Orbital flight 34:16 89 62 to 116 55 to 151 
May 16, 1963 180 
Postflight 
May 16 and Physical (*) 1 77 72 to 82 56 to 
may 17, 1963 examination 88 
*Not determined, not time-critical.


The medical examination performed immediately after the MA-8


recovery suggested an alteration in the pilot's cardiovascular


responses to position changes. To obtain more quantitative meas­

urements of these responses, an operational tilt procedure was


developed for shipboard use using a Stokes' litter with crossbars


added for lifting and stabilization.


Heart rate and blood pressure measurements were taken at least


every minute in all tests and were chosen as the primary indi­

cators of altered functions, in conjunction with observation of


visible reactions and subjective comments. Operational use called


for minute heart rates calculated from 15-second counts of the


right radial pulse, with clinical bl6od pressures taken from the


left arm. Greater capability in the Space Medicine Laboratory in


Hangar S permitted simultaneous determination of both clinical and
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TABLE V.- SUMMARY OF BLOOD PRESSURE DATA 
Date 
February 1959 
to May 15,1963 
Pr~cedure 
Crew selection examina­
tion, special tests and 
preflight examinations

Duration, 
hr:min 
a 
Mean Systole 
 
blood ±2 
 
pressure, Number of standard 
mm Hg values deviation, 
mm Hn
g 
 
Preflight -clinical

1/ 99 to 127 
Range, Number of 
 
mmHg values 
 
88 to 95 
 
124 
 
Diastole 
 
±2 
 
standard 
 
deviation, 
 
mm H& 
 
69 to 89 
 
Range, 
 
mmHg 
 
_ _­
64 to 
 
88

Mean

pulse 
pres­
sure,,

Hg

34

H

September 
1961 to 
May 15, 
1963 
Centrifuge simulations 
and preflight test 
procedures 
Preflight, blood pressure measuring system

56:09 112/79. 160 86 to 138 79 to 
148 
160 58 to 90 
 61 to 
 
124

33

May 15, and 
May 16, 
1963 
Orbital flight-------­
1 
Inflight, blood pressure measuring system 
34:16 119/81 
1 . 
12 b 109 to 
131 
I 
12 b 
 
I 
73 to 
 
89 
I 
38

May 16 and 
May 17,
1963 
Postflight physical 
examinations 
Postflight, clinical 
91/66 16 75 to 107 86to 
i00 
16 55 to 77 
 52 to 
 
82

25

aNot determined; not time-critical.
 
bNot applicable..

BPMS blood pressures and continuous recording of respiration


rate and ECG from the biosensor system. Minute hedrt rates were


determined from the directly recorded biosensor data by using


12-second counts made every 30 seconds.


Minute respiration rates were deterftined from 30-second counts


made each minute. There were no apparent differences between the


clinical and biosensor values.


In short, the preflight tilt test produced expected cardio­

vascular compensatory reactions that could be demonstrated by


heart rate, blood pressure, and ECG data, and all of these tests


were well-tolerated. The postflight tilt tests demonstrated the


presence of moderate orthostatic hypotension, with far greater


heart rates required to maintain effective cardiovascular function.


Compensation was achieved, however, and the pilot did not develop


even near-syncope. Tilt studies of responses after stresses sim­

ilar to those experienced during flight are not available. Con­

tributing stress factors, including heat stress, the effect of


prolonged confinement, dehydration, fatigue, and a possible effect


of weightlessness per se, are thought to be the principal ele­

ments responsible for this change. The picture is further clouded


by residual effects of the dextro amphetamine.


A device for calibrated work consisting of a short plastic


handle and expansible bungee cords was fixed within the spacecraft


near the astronaut's feet. A limiting cable ensured repeatability


of handle travel, requiring 65 pounds of force for each full ex­

tension. At 2:25:00 and again at 7:41:00 GMT, the astronaut re­

corded his blood pressure, pulled the device 30 times in as near


30 seconds as possible, and again recorded his blood pressure.


The results of these two work periods were compared with five


such periods performed at normal gravity in the spacecraft and


in the procedures trainer.


Subjectively, the astronaut could tell little difference be­

tween the work performed under normal gravity and under zero


gravity; the effort under zero gravity was, if anything, slightly


easier. During flight he felt his postwork breathing was not as


labored as it was following control runs, and he thought his


heart rate returned to prework values more rapidly. The data,


however, do not support this statement.


Analysis of the data does not show any striking differences


between the one-g and zero-g work periods. Inflight mean heart


rates- during the calibrated work period were 16 beats per minute


higher than preflight, but the astronaut's inflight mean heart


rate before work was 15 beats per minute higher. (Return to pre­

work values was slower following the inflight exercise.) The


results are presented graphically in figure 1. One preflight
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Figure I.- Calibrated work, MA-9.


heart rate during during work was 160 beats per minute. This


value occurred at the only time in one of the seven periods in


which the astronaut worked over 0.7 minute and probably reflects


the prolongation of the work period rather than indicating a


higher 	 workload. During the 18-second recovery period after the


test, the preflight mean heart rate dropped to 11 beats per minute 
over the preflight value, while during the flight it fell to 17


beats per minute over the prework mean.


GEMINI FLIGHT


The Gemini program consisted of 10 manned space flights in­

volving 20 individuals, two on each flight. A summary of these
 

flights is shown in table VI.


The principal physiological changes noted were orthostatism


(orthostatic hypertension) for some 50 hours after flight as


measured with a tilt table. The Gemini program also provided


extravehicular activity and the resultant monitoring of the
 

cardiovascular system under these new stress conditions.
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TABLE VI.- GEMINI MANNED SPACE FLIGHTS


GeiiLaunch Duration,


Gemini Crew ate Description Darin

mission date 	 day:hr:min


III Grissom March 23, Three-revolution manned test 0:04:52


Young 1965


IV McDivitt June 3, First extended-duration and extra- 4:00:56


White 1965 vehicular activity


V Cooper August 21, First medium-duration flight 7:22:56


Conrad 1965


VII Borman December First long-duration flight 13:18:35


Lovell 4, 1965


VI-A Schirra December First rendezvous flight 1:01:53


Stafford 15, 1965


VIII Armstrong March 16, First rendezvous and docking flight 0:10:41


Scott 1966


IX-A Stafford June 3, Second rendezvous and docking; first 3:01:04


Cernan 1966 extended extravehicular activity


X Young July 18, Third rendezvous and docking; 2 ex- 2:22:46


Collins 1966 	 travehicular activity periods; first


docked target-vehicle-propelled


high-apogee maneuver


XI Conrad September First rendezvous and docking initial 2:23:17


Gordon 12, 1966 orbit; 2 extravehicular activity


periods; second docked target­

vehicle-propelled high-apogee


maneuver; tether exercise


XII Lovell November Rendezvous and docking; umbilical and 3:22:37


Aldrin 11, 1966 two standup extravehicular activity


periods; tether exercise
 

The cardiovascular system was the first of the major body


systems to show physiological change following flight; as a re­

sult, it has been extensively investigated by various means (table


VII). As previously reported, the peak heart rates have been


observed at launch and at reentry; the rates normally reached


higher levels during the reentry period. The midportions of all


the missions have been characterized by more stable heart rates


at lower levels with adequate response to physical demands.
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TABLE VII.- CARDIOVASCULAR OBSERVATIONS


Experiment Objective -Instrument Time Measurement 
Cardiac Heart Synchronous Before, Heart sounds 
condition phonocardiograph during, QRS complexes 
mechanics ECG and after -
flight 
M003 Cardiovascular ECG, SPCG Before, - Heart sounds 
cardiovascular under stress BPMS during, QRB waves 
stress Bungee device and after Korotkov 
flight sounds 
Brachial 
pressure 
Cardiovascular Heart rate ECG, BPMS Before, -Heart sounds 
Mean blood Tilt table during, QRB waves 
pressure and'after Korotkov 
flight sounds 
Brachial 
pressure 
Cardiovascular Heart rate Bicycle 'Before, Heart sounds 
Mean blood Ergometer during, QRB waves 
pressure and after Korotkov 
flight sounds 
Brachial 
pressure 
The electrocardiogram has been studied in detail throughout


the Gemini missions. The only abnormalities of note have been


very rare, premature, auricular and ventricular contractions. No


significant changes have been detectedT in the duration of specific


segments of the electrocardiogram.


Blood pressure measurements obtained during the Gemini VII


mission revealed that systolic and diastolic values remained within


the envelope of normality and showed no significant changes


throughout 14 days of flight. As previously reported, this in­

cluded the pressures taken at the time of reentry.


Some insight into the electrical and mechanical phases of the


cardiac cycle was gained during the Gemini flights. The data were


derived through synchronous phonocardiographic and electrocardio­

graphic monitoring. In general, wide fluctuations in the duration


of the cardiac cycle, but within physiological limits, were ob­

served throughout the missions. Fluctuations in the duration of


electromechanical systole correlated closely with changes in heart


rate. Stable values were observed for electromechanical delay


(onset of ventricular activity, QRS complexes, to onset of first


heart sound) throughout the missions, with shorter values observed
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during the intervals of peak heart rates recorded during liftoff,


reentry, and extravehicular activity. The higher values observed


for the duration of systole and for electromechanical delay in cer­

tain crew members suggest a preponderance of cholinergic influ­

ences (vagal tone). An increase in adrenergic reaction (sympathetic
 

tone) was generally observed during liftoff, reentry., and in the
 

few hours preceding reentry.


As a further measure of cardiovascular status, experiment


M003, inflight exerciser, determined the heart rate response to


an exercise load consisting of one pull per second for 30 seconds


on a bungee device (force at full extension of 12 in. equaled


70 lb). The results of the 4-day Gemini IV and the 14-day Gemini


VII mission did not differ. This variant of the step test re­

vealed no physical or cardiovascular decrement after as much as


14 days in a space-flight environment.


In contrast to the Mercury project results, orthostatism re­

sulting from any Gemini mission has not been detectable except by


means of passive tilt-table provocation. Typically, the heart


rate and blood pressure responses to a 15-minute, 70-deg tilt


performed after flight are compared with identical preflight test­

ing of the same crewmen. Consistently, such testing has demon­

strated a greater increase in heart rate, a greater reduction in


pulse pressure, and a greater increase in leg volume, as in­

terpreted from lower limb circumference gages during the pre­

flight tilt (fig. 2). The changes observed in these variables


may be most significantly illustrated by examining the heart rate


changes observed during preflight and postflight tilt-table
 

studies. When the postflight increases in heart rate during tilt


are expressed as percent of the preflight tilt heart rate for each
 

of the Gemini crews, the postflight increases are from 17 to 105%


greater than those exhibited before flight.


The Gemini flights have also provided some excellent examples


of human variability and have emphasized the necessity for care
 

in making deductions. In making projections based on very limited


results in a few people, the current trend is to bank heavily


on comparisons in a given individual; that is, differences be­

tween baseline data,and responses observed during and after a


flight. The crewmen who have flown twice have shown variability


between flights in the same manner as have different men on the
 

same flight. Figure 3 shows the heart rates for one crewman
 

during the launch phase of both his Mercury mission and his Gemini
 

mission. The two curves show little correlation and could easily


have come from different individuals.
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Figure 3.- Command pilot heart


Figure 2.- Typical tilt-table response. rate comparisons.


Apollo Flight


The Apollo program consisted of 11 manned flights including


lunar landing. A summary of these flights is given in table VIII.


TABLE VIII.- APOLLO MISSION CHARACTERISTICS AND ORTHOSTATIC


EVALUATION TECHNIQUES


Time from Length Time from Type of 
liftoff of lunar lunar Total mission duration orthostaticApollo Type of mission to lunar stay, hr liftoff to Hours Days 
 evaluation 
mission landing, hr splash- performeddoiml, hr 
7 Earth orbital 260.1 10.8 LBNP 
8 Lunar orbital 147.0 6.1 LBNP 
9 Earth orbital 241.0 10.0 LBNP, Stand 
10 Lunar orbital 192.0 8.0 Stand 
11 Lunar landing 102.7 22.2 70.9 194.0 8.1 stand 
12 Lunar landing 110.5 31.5 102.0 244.5 10.2 -­
13 Lunar-abort 142.9 6.0 
14 Lunar landing 108.2 33.5 74.3 216.0 9.0 -­
15 Lunar landing 104.7 67.0 123.6 295.0 12.3 LBNP 
16 Lunar landing 104.5 71.0 90.3 265.8 11.1 LBNP 
17 Lunar landing 110.3 75.0 116.5 301.8 12.6 LBNP 
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Reductions in orthostatic tolerance following flight were


observed with the late Mercury flights. Elevated heart rate, re­

duced pulse pressure, and increased pooling of fluid in the lower


extremities were found consistently during 70-deg upright tilts


in the early postflight period.


Several techniques were used to induce cardiovascular re­

sponses. They include the tilt table and the lower body negative


pressure (LBNP) systems as simulators of orthostatic stress.


In addition, antihypotensive garments were tested. These in­

cluded Jobst waist-length leotards and a garment employing the


capstan principle for the application of lower body positive


pressure. The methods ,and conditions 'affecting orthostatic eval­

uation are described in the following section.
 

Lower body negative pressure device.- The device for measuring


LBNP consisted of a chamber of sufficient size to accommodate the


lower body, an airtight waist seal, and a regulated Tacuum source


(Wolthuis et al., 1970; Wolthuis et al., 1972). The type of


physiological measurements taken during the LBNP protocol varied


slightly from mission to mission. Measurements made in conjunc­

tion with the Apollo 7 to 9 missions included continuous axillary


and sternal lead electrocardiograms, indirect blood pressure taken


every 30 seconds by the Korotkov sound technique (using the NASA


Gemini blood pressure measuring system), and changes in calf


circumference measured by double-strand, mercury-in-silastic


strain gages.


For the Apollo 15 to 17 evaluations, the limited two-lead
 

electrocardiogram was replaced with a modified Frank lead vector­

cardiogram (VCG) and wadeband precardial heart sounds (vibrocar­

diogram) were recorded with a capacitance microphone system. The


respiration rates of the Apollo 16 and 17 crewmen were measured
 

with a mercury strain gage attached to the lower thorax. The


carotid pulse trace was recorded for Apollo 17 crewmen.


A Jobst waist-length elastic leotard was used in the Apollo


16 mission. This garment produced a pressure at the ankle of 40


to 45 mm Hg (53 x 102 to 60 x 102 N/m2) that decreased linearly


to approximately 10 mm Hg (13 x 102 N/m2) at the waist. To


accommodate expected reductions in limb size during flight,


garments were made in three separate sizes.


A lower-body garment using the capstan principle to apply


pressure to the lower limbs was provided for the Apollo 17 com­

mand module pilot to use following splashdown. Capstan pressure


was read from an aneroid gage and was inflated with a hand bulb,


both of which were concealed in a zippered pocket. The capstan


exerted the pressure of the garment over the skin at the ankle
 

in a 2:1 ratio. This pressure diminished linearly to approximately


16 
10 mm Hg (13 x 102 N/m2) at the aist. Preflight testing with


pressure sensors between the garment and the skin verified the


ratio and the diminishing gradient of pressure from ankle to


waist. To accommodate anticipated loss of limb girth, laces


were provided for reducing the garment size slightly before


stowage in the command module. The capstan itself accommodated


moderate changes (±2.5 cm) in limb girth.


Accessory cardiovascular and related measurements were made


to evaluate orthostatic changes. Before orthostatic evaluation


of the Apollo 7 to 11 and 15 to 17 crewmen, the circumference of


the calf at its maximum girth was measured during supine rest.


The total lower limb volume of Apollo 16 and 17 crew members


were calculated from multiple leg circumference measurements


made at discrete intervals from the ankles to the groin while


the crewman was supine with the legs extended and slightly ele­

vated. Standard 1.8-m (6-ft) posterior-anterior chest X-rays


were taken of every crew member at his last major preflight


medical examination and first postflight evaluation. The cardlo­

dothoracic ratio was determined by standard clinical methods.


The ambient temperature and the oral temperature and body weight


of each crewman were recorded at each evaluation.


Results.- Of the various cardiovascular measurements obtained
 

from Apollo crew members during their evaluations, heart rate


was the most easily measured and yielded the most accurate and.


predictable values. Table IX contains heart rate data on in­

dividual crew members during three conditions of orthostatic


stress evaluations: (1) resting supine control, (2) the highest


level of LBNP [-50 mm Hg (-67 x 102 N/m2)], and (3) passive stand­

ing. The resting supine heart rate was elevated significantly'
 

in 13 of 24 crewmen (54%) at the first postflight evaluation;


the group response was elevated at the 2% level of confidence.


A trend toward preflight values was subsequently evident. By the
 

third postflight evaluation, only three of 15 individuals (20%)


showed significant elevations in the resting supine heart rate,


and the group mean value was not statistically different from


the preflight group mean heart rate (n = 15, paired).


Following the same comparisons, the application of 50 mm Hg


(-67 x 102 N/m2) £BNP produced significantly elevated heart rates


in 14 of 17 Apollo crewmen (82%) at the first postflight evalua­

tion, with a group elevation significant at the 0.1% level. The


Apollo 15 lunar module pilot experienced presyncope during thc


last seconds of -40 mm Hg (-53 x 102 N/m2 ) IBNP and was not tested


at -50 mm Hg (-67 x 102 N/m2) LBNP on recovery day. Five other


crew members (the Apollo 8 command module pilot, the Apollo 8'


lunar module pilot, the Apollo 9 lunar module pilot, the Apollo


16 command module pilot and the Apollo 16 lunar module pilot


developed presyncopal symptoms at some point before protocol
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TABLE IX.- INDIVIDUAL APOLLO CREW MEMBER HEART RATE DATA 
(ARROWS INDICATE p <0.05) 
summaryProtcolGewApolo refightevauatons Preflight Postflight evaluations
Protocol Apollo Grew Preflight evaluations	 _ s -mna_ 

condition mission 
merBer F-30 days F715 days V-5 days iean ±8D First Second Third 
Resting 7 CDR 56 59 54 56 2.6 77 - 59 -­
supine CM 81 74 78 78 31 78 76 -­
control LM 57 64 66 62 4 4 75 '70 -­
period 8 CDR 74 69 70 71 2.6 87 - 70 80 

Clip 84 69 66 73 9 7 94 76 66 

LIT 77 74 72 74 2.4 91 - 81 - 71 

9 	 CDR 76 63 68 69 6.8 64 78 80 
0M 56 59 58 57 2 0 57 54 53 
LIE 59 55 57 57 2 1 50 - 50 * 50 
10 	 CDR 62 70 59 64 5.7 81 * 73 --
CbT 65 59 55 60 5.0 65 62 --
LMP 59 62 52 58 5 1 80 79 - -­
11 	 CDR 61 62 67 63 3 2 69 79.-.. --
CMP 53 46 51 50 3.6 67 65 - --
IMP 68 69 70 69 1.0 62 - 81 - -­
15 	 CDR 51 50 55 52 2 6 54 50 52 
CIT 66 69 70 68 2 1 83 84 - 73 
LMP 52 56 57 55 2.6 66 * 66 * 66 
16 	 CDR 57 57 55 56 1 2 70-a 60.. 61 
C0p 49 49 45 48 Z 1 56 * 48 56 
LI 60 53 54 36 3 9 57 61 60 
17 	 CDR 55 62 59 59 3.2 67 a 70 - 64 
GMB 78 76 68 74 5.1 67 64 69 
Lie 50 50 51 50 0.6 55 - 56 - 52 
Group Mean 62 8 61 5 60.7 61.6 69 7 67 2 63.5 
±SD 10.47 8.53 8.41 8.60 12.19 10.90 9 88 
2 

Lmp 	 t-Test p<O.0 ts as 

-50mm 7 CDR 72 61 59 64 6.7 90 - 67 ­
jhg* Cie 94 92 90 92 2.1 137 a 94 --
LBNP LMP 76 74 76 75 1.1 108 - 87 - ­
8 	 CDR 100 86 94 93 6 7 159 - 108 101 

Cm? 116 89 94 99 14 5 129 121 88 

LM 97 105 106 103 4.8 146 - 137 102 

9 	 CDR 82 67 78 76 7,9 100 - 94 93 
C0M 63 73 76 71 6.9 81 70 68 
LM 74 70 67 70 3.3 87 - 75 65 
15 	 CD0 - 62 59 61 61 1.5 76 - -- 65 
OMP 79 81 81 80 1,2 131 - 109 - 93 
LMP 58 56 64 59 4.2 -- 84 - 78 
16 	 CDR 79 71 72 74 4 1 109 - 101 - 83 

CUP 62 67 58 62 4.2 99 - 74 - 79 

IP 82 72 83 79 5.9 112 - 98 - 98 

17 	 CDR 67 78 71 72 5 3 112 - 91 - 78 

cm 87 86 79 84 4.3 87 78 90 

L 59 69 60 63 5.4 82 - 80 - 60 

Group Mean 78 3 75.3 76.1 76.5 108.5 92.2 82.7 
±SD 15.97 12.61 13 70 13.27 24.58 18.85 13.76 
t-Test p<O.O01 p<0.02 us 
Passive 9 CDR 81 73 79 78 4.2 93 - 100 - 96 
Stand C01? 66 75 72 71 4.6 88 - 72 70 
1-JP 71 67 69 69 2.0 93 - 79 - 65 
10 	 CDR 86 93 86 68 4.o ii - 92 -­
0mB 88 85 70 81 9 6 100 81 --
LMP 80 74 70 75 5.0 121 - 109 . -­
11 	 CDR 73 83 85 80 6.4 112 - 105 t --
Cli 76 69 65 70 5.6 91 - 88 - --
LMP 73 76 79 76 3.0 89 - 100 - --
Group Mean 77.1 77.2 75.0 76.4 99 8 91.8 77.0 
±SD 7.22 8.29 7.48 6.11 11.99 12.71 16 64 
t__ <0.001 pO02. us-Teat .

--67 x 102 N/M
2 .
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completion during their immediate postflight 50 mm Hg (-67 x 102


N/m') stress; the Apollo 15 commander experienced similar symptoms


during his second postflight evaluation. Although more crew mem­

bers immediately after flight demonstrated a larger heart rate


increment over preflight values during LBNP stress than during


the resting control period, statistically significant group dif­

ferences disappeared by the third postflight evaluation. Passive


vertical standing results indicated a similar increase in heart


rate immediately after flight.
 

In table X, heart rates of Apollo crew members are compared
 

with those of control subjects for three protocol conditions.


Significant "postflight" heart rate changes among the control


subjects onboard the recovery ship were not observed. Although


the control subjects were exposed to similar environmental con­

ditions, all had a five- to 10-day acclimatization period onboard
 

the recovery ship preceding their evaluations.


TABLE X.- APOLLO CREW MEMBER VERSUS CONTROL
 

SUBJECT HEART RATE DATA


Preflight summary Postflight evaluations 
Protocol Apollo Response First Second 
condition group SD, SD N X p N X p 
i t 
Resting supine I CGrew controls 24 22 61.6 69.7 8.60 6.93 1.06 1.00 24 22 69.7 69.4 0.02 ns 24 10 67.2 70.4 0.05 ns 
-50 mm Hg* 
LBNP J 
Crew 
controls 
18 
16 
76.5 
85.1 
13.27 
8.14 
1.55 
1.49 
17 
14 
108.5 
87.3 
0.001 
ns 
17 
9 
92.2 
84.2 
0.02 
ns 
Standing Crew 9 76.4 6.11 1.24 9 99.8 0.001 9 91.8 0.01 
controls 7 79.6 6.40 2.72 7 81.1 ns 
*-67 x 102 N/mZ . 
Note: N = Number of subjects 
K = Group mean 
SD = Standard deviation of crew member preflight summary means 
SD t = Standard deviation of three preflight group means 
p- = Probability level 
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Skylab Medical Experiments Altitude Test (SMEAT)


The objectives of SMEAT were to provide a nearly full-scale


simulation of a 56-day Skylab mission. Through this simulation,


all crew procedures and equipment operations could be tested.


The specific SMEAT objectives were to:


1) 	 Obtain and evaluate baseline medical data for up to 56


days;


2) 	 Evaluate selected experiments, hardware systems, and


ancilliary equipment;


3) 	 Evaluate data reduction and data handling procedures in


a mission duration time frame;


4) 	 Evaluate preflight and postflight medical support opera­

tions, procedures, and equipment;


5) 	 Evaluate medical inflight experiment operation procedures
 

and crew checklists;


6) 	 Train the Skylab medical operations team for participa­

tion during the flight.


The specific experiments relating to the cardiovascular system


are discussed in the following paragraphs.


M092 lower body negative pressure.- The objectives were to


obtain baseline data concerning the time course of cardiovascular


deconditioning during long-term residence in zero-g and predict


the degree of physical impairment that may be experienced on re­

turn to earth's gravity, and to obtain verification of procedures


and crew operational capability.


M093 vectorcardiogram - The objective was to determine refer­

ence data and changes in the electrical activity of the heart


caused by exposure to the Skylab atmosphere and other specific


stressors and to correlate the changes detected with those known


to occur after specific stress in normal environments.


The equipment functioned well. Data loss was minimal and was


mainly due to shortcomings in the software programs. The Skylab


environmental specifications were maintained throughout this ex­

periment with temperature ranging from 21 to 260C. Despite the


temperature fluctuations, there were no gross differences in


cardiovascular responses and no signs of impending syncope.


Table XI gives the mean physiological values for the prechamber,


in-chamber, and postchamber periods and indicates statistically


significant changes.
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TABLE XI.- LBNP PHYSIOLOGICAL MEASUREMENTS


Control 	 -50 = Hg LBNP


Heart Systolic Diastolic Heart Systolic Diastolic PLVC


N rate BP BP rate BP BP
S±SD X ±SD X ±SD X ±SD X ±SD X ±81D X ±SD) 
Commander 
Prechamber 5 '51 4 99 2 65 3 56 2 99 4 67 4-- 3.1 0.3


In-chamber 18 52 3 102 4 64 3 60 6 101 5 65 ;_3 '.2- 0.4 
1 61 110 73 69 100 65 
Scientist-pilot


Prechamber 4 53 5 102 6 68 8 59 7 96 6 69 7 3.1 1.0


In-chamber 17 48 2 96 4 62 4 54 2 92 4 62 4 3.0 0.3


Postchamber 1 51 102 63 55 96 64 3.6


Pilot


Prechamber 4 70 9 119 3 69 4 75 11 112 7 74 , 1 3.0, 1 0 
In-chamber 18 77 6 123 9 69 5 82 5 116 10 76 J35 13'0s3 0.4 
Postcamber 1 69 112 1 61 1 77 97 J 634- - 2-5 
Note: 	 Arrows indicate direction and statistical significance of change - one arrow p>0.05.'


tp values were determined from fiducial limits computed by t-test.


Heart rate.- Since increased heart rate is one of the most 
effective ways of increasing cardiac output in the face of greater, 
physiological demands, heart rate was used as the major singl&- -, 
determinant of altered orthostatic response. In:chamber mean heat, 
rates and postchamber individual values were compared with the pre-I 
chamber mean. Table XI shows that throughout the 56-day test, the 
commander exhibited an increase in heart rate, both at rest and at 
reduced pressure. His postchamber values were significantly higher 
than the respective prechamber means. The scientist-pilot and 
pilot showed no significant changes in heart rate. 
Blood pressure.- The blood pressure values of the commander


showed increased postchamber control values, the scientistpilo


showed no significant variation, and the pilot exhibited a statis-'


tically significant decrease in both systolic and diastolic blood


pressures. None of the crew members showed significant pulse


pressure changes.


An unanticipated finding was detected during preliminary in­

spection of heart rate and blood pressure time graphs. Time


series analyses for periods longer than one day produced statis­

tically significant periodicity across different data sets, for


the same individual. All three crew members showed approximately
 

monthly rhythms.
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Vectorcardiography.- Compared to the prechamber baseline


tracing, no significant changes of rhythm were observed in the


crew members' VCG recordings. Any changes in the mean values of


the PR, QRS, and QT intervals closely followed the changes ob­

served in heart rate.


Percent Leg Volume Change.- Analysis of resting supine leg


calf circumference showed a progressively decreasing linear


trend. By statistical regression of the calf circumference values


versus time, an estimate of the percent change was computed as


the difference between intercepts at the first in-chamber day and


postchamber day.


The decrease in leg calf circumference, together with the body


weight loss, is summarized in table XII. The commander and scien­

tist-pilot showed a decrease in both leg calf circumferences and


a concomitant body weight loss. The excessive weight loss of the


scientist-pilot can be partially attributed to a 500-calorie


deficit in his daily diet. The pilot showed a decrease only in


the right leg circumference.


TABLE XII.- CALF CIRCUMFERENCE AND BODY WEIGHT LOSS


Commander Scientist- Pilot 
pilot


Initial left calf circumference, 35.8 42.4 38.7


cm


Slope, cm/day 
-0.011 -0.015 -0.000


Intercept (R + 0), cm 35.2 41.6 38.7


Percent decrease 1.7 2.0 0.0


Initial right calf circum- 35.8 43.5 38.6


ference, cm


Slope, cm/day 
-0.017 -0.018 -0.008


Intercept (R + 0), cm 35.0 42.5 37.8


Percent decrease 2.2 2.3 2.0


Body weight loss, kg -1.81 -5.45 0.0


The percent leg volume change remained unaltered throughout


all periods of the chamber study, and the experimental data sug­

gest that a decrease in the absolute leg calf circumference had


no effect on the percentage leg volume change during LBNP stress.


Both the Skylab LBNP hardware and data acquisition system


operated satisfactorily. Previous studies of individuals con­

fined in hypobaric chambers where physical activity was severely


limited have shown evidence of reduced orthostatic tolerance.


Similarly, it has been reported that even strict four-day chair
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rest can produce this effect. In the M092 experiment, the astro­

nauts entered the hypobaric chamber in good physical condition


land exercised daily. These were undoubtedly factors in the main­

tenance of physical fitness. Impaired orthostatic tolerance,


manifested by the increased heart rate, diminished systolic and


.pulsepressure, and increased tendency to syncope in the upright


position (or during LBNW), was not observed in this experiment.


Skylab Flight


One of the objectives of the Skylab program was to study man's


response to long-duration space flight. In the cardiovascular


area it appears that cardiovascular deconditioning does occur


during flight, that the change is adaptive in nature and stabil­

izes after a period of four to six weeks, that this change does


not impair crew health or performance aloft, and that it is


triggered by factors tending to reduce circulating blood volume.


These changes and observations, as summarized by Dietlein (1974),


are shown in tables XIII and XIV.


TABLE XIII.- SKYLAB CARDIOVASCULAR SUMMARY


* Cardiovascular deconditioning was observed during flight; changes


appear adaptive in nature and tend to stabilize after 4 to 6 weeks.


* Cardiovascular changes do not impair crew health or ability to


function effectively in weightless flight.


* Lower body negative pressure tests provide a fairly reliable pre­

dictive index of postflight cardiovascular status.


* Cardiac electrical activity, as measured by vectorcardiogram, was


not significantly altered and remained within physiological limits.


* Decreased cardiac output noted in crewmen after flight; thought to


be related to reduced venous return.


* Single episode of significant cardiac arrhythmia in one Skylab 2


crewman during exercise early in mission.


* No significant inflight decrement in work capacity or physiological


responses to exercise.


* All crewmen have shown postflight decrease in exercise capacity and


altered physiological responses.


" Skylab 3 and 4 crews returned to preflight cardiovascular status by


the fourth and fifth day and the Skylab 2 crew on the 21st day after


flight; increased exercise by Skylab 3 and 4 crewmen thought to be


a factor in improved recovery rate.
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TABLE XIV.- CARDIOVASCULAR SYSTEM


Findings


" Postflight orthostatic intolerance


* Postflight diminished exercise capacity


Probable etiological factors


* Decreased effective circulating blood volume after flight 
* Diminished venous return at one-g 
" Muscular imbalance occasioned by functional disuse atrophy of


antigravity muscles


* Altered internal milieu (fluid/electrolyte dynamic flux) during


early postflight period


* Altered venous reflexes/tone


* Fatigue


The lower body negative pressure test has proved to be a


fairly reliable predictive index of postflight cardiovascular


status. Cardiac arrhythmias have been rare; only one episode was


noted early in Skylab 2 during intensive personal exercise and


was interpreted as multiple, unifocal ventricular premature beats


with no evidence of coupling.


Other arrhythmias observed have been limited to isolated rare


to occasional premature beats. Cardiac electrical activity has


been within physiological limits as judged from the vectorcardio­

graphic data.


Exercise tolerance during flight was unaffected. It was only


after return to earth that a tolerance decrement was noted.


Finally, the rapid postflight recovery of orthostatic and


exercise tolerance following two of the three Skylab missions


appears to be directly related to total inflight exercise as well


as to a graded regular program of exercise during the postflight


debriefing period.


There is no convincing incidence of myocardial damage as an


etiological factor; however, transient cellular changes during


the period of homeostatic perturbation would not be surprising


or unusual. In animal oxygen toxicity studies we have observed


such changes in lung, liver, and kidney.
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The thrust of future cardiovascular investigations as sum­

marized by Dietein (1974) is indicated in table XV. Continued


human studies, as well as critical invasive experiments with


animals, must be conducted to define the time course of per­

tinent mechanisms. The Gauer-Renry reflex has yet to be demon­

strated. This will not be easy to demonstrate in man since the


critical time period to be investigated is thought to coincide


with the early operationally exacting first day of the mission.


TABLE XV.- SUGGESTED FUTURE INVESTIGATIONS


" In-depth, noninvasive cardiovascular dynamics monitoring


* Invasive pressure/volume/flow changes in early flight (animal)


" Demonstrate presence or absence of Gauer-Henry reflex


* Total body exercise regime to maintain integrity of antigravity


as well as major muscle groups


* Assess role of venous (capacitance) vessels in observed decon­

ditioning process


* Assess role of fatigue


* Devise exercise program for all major muscle groups


* Assess roles of capacitance vessels or veins in the decondi­

tioning phenomena


Life Sciences Spacelab Payload Simulation I


During October 1974, NASA-JSC conducted a seven-day simulated
 

life sciences mission in a Spacelab mockup. It contained 12 ex­

periments in human biomedical and animal cardiovascular research,


plant growth and microbiological studies,-biochemical determina­

tions, and other similar studies.


The objectives of the simulation included evaluation of in­

orbit Spacelab operations, payload operations, related mission


control functions evaluation, and preliminary Spacelab systems and


ground support facilities design.


An experiment (LSI-2) on cardiovascular physiology and cellular


repair was conducted in which chronically implanted sensors and


Skylab noninvasive sensors were used to assess the cardiovascular


system of a large mammal during simulated zero-g conditions. The


objective was to evaluate the response of the cardiovascular system


to standardized stresses such as fluid loading, drugs, and envrion­

mental factors. Healing responses and cellular analyses of specific


organs were also evaluated to assess cardiovascular changes. The


results of this simulation were useful in providing a better per­

spective of payload operations and future life science payload


definition.
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Life Sciences Spacelab Mission Simulation II


Fifteen experiments were performed during a seven-day simu­

lated Shuttle mission to gain integration and operational insights


of Shuttle life sciences mission planning and preparation. The


experiments were selected as a function of relevancy -and teck­

ifical suitability. The experiments, as defined by NASA-JSC, are


summarized in table XVI.


One significant observation was that individuals with tatoos


or long-term markings for positioning the vectorcardiogram leads


exhibited less deviation than those without position indicators.


Bed-Rest Studies


Recent bed-rest studies have been performed. In July 1976,


28-day experiments for a Skylab I simulation were conducted.


These experiments included the lower body negative pressure sys­

tem. In studies involving orthostatic countermeasures via a
 

dietary approach, it was found that beef boullion provided
 

positive short-term effects. The normal parameters, i.e.,


systolic time intervals, absolute leg volume, etc were measured.
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TABLE XVI.- SMS II 
Number 	 Title 
 
SMS I1-1 	 Hemodynamic changes following 
 
exposure to weightlessness 
 
SMS 11-2 	 Central and peripheral hemo-

dynamic responses during 
 
isometric exercise 
 
SMS 11-3 	 The effect of orbital fluid 
 
shifts on cardiovascular 
 
dynamics 
 
SMS 11-4 	 The effect of zero-g fluid 
 
shifts on the vectorcardiogram 
 
SMS 11-5 	 Echocardiography 
 
SMS 11-6 	 Hemopoietic function of bone 
 
marrow 
 
SMS 11-7 	 Pulmonary blood flow 
 
SMS TI-8 	 Respiratory physiology and 
 
pulmonary function 
 
SMS 11-9 The effect of zero-g fluid on 
 
thermoregulation 
 
SMS II-10 Vestibular function 
 
SMS 11-11 	 Acute fluid and electrolyte 
 
metabolism responses to space 
 
flight 
 
SMS 11-12 	 Study of skeletal muscle 
 
muscle function in space flight 
 
SMS 11-13 	 Salivary analysis 
 
85 11-14 	 The effect of zero-g on muscle-

like contractile proteins 
 
SMS 11-21 	 Cosmic ray magnetic spectrometer 
 
EXPERIMENTS 
Description


Study quantitative changes in limb blood


flow and relative pulse wave velocity/


time during and after flight.


Evaluate the 	 effect of space flight on


cardiovascular responses to isometric


exercise.


Determine by 	 myocardial responses re­

flected in systolic time intervals,


central volume loading effects caused


by headward fluid shifts and temporal
 

course after orbit.
 

Determine by 	 inflight vectorcardiogram,


etiology and consequences of fluid shifts,


and potential countermeasures.


Evaluate changes in dimensions and


cardiac mechanical and electrical


function throughout cardiac cycle.


Collect samples of bone marrow and


hemopoietic tissue from experimental
 

animals to evaluate functional aspects
 

of the hemopometic processes during


space flight.


Obtain data on the time course and magni­

tude of changes in central blood flow/


volume relationships in zero-g by


measuring pulmonary blood flow.


Examine physiological mechanisms in­

volved in adaptation of pulmonary system


in zero-g and readaptation to earth


gravity.


Assess the effect of zero-g on the rate
 

of heat transfer from the body.


Obtain electronystagmograph responses of


human vestibular system to variable


angular acceleration.


Identify acute changes in systemic


physiologic factors that occur upon


introduction 	 of zero-g.


Evaluate muscle dysfunction character­

istics and consequences resulting from


space-flight 	 disuse.


Measure selected parameters of parotid


saliva and relate to both oral and


general health.


Determine effects of zero-g using


rhythmic reversible protoplasmic

streaming of 	 the myxomycetes.


Measure the momentum and electrical


charge of nuclei from cosmic radiation.
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INSTRUMENTATION


Numerous biomedical instruments to detect and quantitatively


measure the various living processes within the body have been de­

veloped. Numerous techniques and transducers- have also been de­

veloped with the intent of converting physiological events into


observable and recordable signals. This has resulted in the even­

tual development and utilization of specialized signal processing


and display devices. The ultimate use of implantable transducers


has, in some cases, even necessitated the use of biotelemetry trans­

mitters to provide the observed subject with full physical freedom.


Various methods are used to convert a physiological event to an


observable, e.g., resistance, capacitance, inductance, fluidic,


ultrasonic, chemical, electromagnetic, mechanical, and electro­

mechanical techniques.


This chapter is intended to summarize the various generic types


of instrumentation applicable to cardiovascular deconditioning moni­

toring. Both invasive and noninvasive instrumentation are included.


While this summary is inclusive of representative state-of-the-art


instrumentation, ft Is no ll-inclusive in that candidaEe selec­

tion was tempered by the intended space-flight application and no


attempt was made to provide an historical treatise on biomedical


instrumentation. Furthermore, the fundamental principles used to


transduce physiological phenomena into electrical signals are best


described in detail in textbooks such as Geddes and Baker (1975).


Techniques and instrumentation are required that will allow


better observation of man in space to determine physiological


changes as-a-function of the spacecraft environment over a given


period of time. Selection of applicable cardiovascular performance


monitoring instrumentation is a function of many factors, including:


1) Specific physical properties to be measured;


2) Mission and spacecraft constraints;


3) Development/modification and implementation costs;


4) Historical techniques and instrumentation used;


5) Experimenter bias;


6) Human application versus human surrogate use;


7) Interfacing with common operational research equipment;
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8) Developmental status or clinical use; 
9) Class of life sciences laboratory;
I 
10) Intended use as flight hardware or for ground-based use. 
Because of several of the above factors, interviews were con­

ducted with various knowledgeable biomedical experimenters includ­

ing those not necessarily associated with the current Space Shuttle/


Skylab program. The intent was to gain a fresh insight into what


might constitute a near-optimum set of cardiovascular decondition­

ing 	 monitoring instrumentation.


Results of previously completed NASA studies provided a base­

line set of data defining life sciences cardiovascular research


requirements for Spacelab. These data were analyzed and updated


to incorporate inputs from recent life sciences space research re­

sults and other inputs obtained during working sessions wLth NASA


scientists and the biomedical community at large. The new inputs


were integrated with applicable baseline data into a set of re­

lated function and measurement requirements and a suggested time


sequencing of research activities. Figure 4 illustrates the work


flow employed to reach the objectives of this task.


A literature search was initiated by a thorough review of per­

tinent data defining life sciences space research requirements.


The data extracted from the multiple input sources resultedin-.the


generation of a set of requirements for assessment of cardiovascular


deconditioning during space flight.


The pertinent sources used in the literature search fdr the


evalution-of-instrumentation and techniques were:


1) 	 MEDLARS;


2) 	 JSC archives;


3) 	 Industry report;


4) 	 Denison Library, University of Colorado Medical Center;


5) 	 Research reports acquired during visits to the biomedical


community and conferences.


The individuals listed in table XVII were contacted at their


respective institutions to gain a more current insight into po­

tentially applicable techniques and instrumentation. Because the


published literature must necessarily lag actual developments,
 

researchers known to be active in~cardiovascular instrumentation


were contacted for update data in their respective areas.
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Figure 4.- Cardiovascular measurement system flow chart.


TABLE XVII.- BIOMEDICAL COMMUNITY CONTACTS


Name 
 
E McCutcheon, ND 
 
R. Simmons, VHD 
 
J Tremor 
Bruce Payton, MD 
 
Robert Grover, HD 
 
Clyde Tucker, MD 
Jack Reeves, MD 
Natalin Banchero, MD 
Don Dick, PhD 
James D Meindl, PhD 
Ingvar Sodal 
Francis D McLeod, PhD 
Slonim N Balfour, MD, PhD 
Robert Johnson, MD 
G W. Hoffler, M D 
Stuart A Bergman, ED 
Sam Pool, ND 
Margaret M. Jackson 
C J. Hartley, PhD 
 
Charles F Savin, PhD 
H G. Hanley, N) 
T' Wztingham, MD 
Gene Schmidt, MD 
Wen Ko, PhD 
Dough O'Hanley, PhD 
David Flemming, MD 
 
Thomas B Fryer 
Samuel Fox, ND 
 
Dennis Battock, MD 
Edward Miller, MD 
 
William Rector, MD 
Phil Green 
Institution


Chief Medical Officer in Cardiovascular Research Lab ­

NASA-ARC 
NASA-ARC Veterinarian


Program Manager for Animal Holding Facility - NASA-ARC 
Department of Surgery. University of Colorado Medical 
Center (UCMC) 
Department 0 f Surgery, UCMH 
Department of Surgery, UCMC 
Department of Surgery, UCMC 
Physiology Department, UCNC 
Biomedical Engineering Department, UCMC 
Integrated Circuits Laboratory, Stanford University 
Instructor of Medicine, UCMC 
Department of Physiology and Biophysics, Colorado State 
University


Cardiopulmonary Diagnostic Lab oratory in Deaver 
Space/Clinical Medicine Branch - NASA-JSC 
Space/Clinical Medicine Branch - NASA-JSC 
Space/Clinical Medicine Branch - NASA-JSC 
Chief, Space/Clinical Medicine Branch - NASA-JSC


Space Physiology Branch, Respiratory Physics - NASA-JSC 
Methodist Hospital, Texas Medical Center, Houston


Space Physiology Branch, Respiratory Physics - NASA-JSC 
Cardiovascular Research, Methodist Hospital, Texas Medical 
CenLer, Houston 
RAF Life Sciences Collaboratory at NASA-JSC 
Biomedcal Technology Transfer Team, Stanford University 
School of Medicine 
Case Western Reserve University 
Technology Utillzatlon, JPL 
Case Western Reserve University


Head, Invasive Biomedical Sensor Technology - NASA-ARC 
Georgetown University


Rcee Memorial Hospital 
Chairman, Department of Medicine, General Rose Memorial


Hospital, Denver CO


Director, Division of Ultrasound, Department of Radiology,


General Rose Memorial Hospital, Denver CO


Program Manager for Ultrasonics, SRI
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Many of their comments and thoughts have been incorporated in this


study. Information sought throughout the technology review included


future research requirements considered essential to the space pro­

gram planners and science community.


Previous manned space programs showed that the cardiovascular


iystem exhibited adaptive changes after entry into the zero-g en­

vironment that reduced the normal tolerance for reentry and landing


stresses. The referenced source documents in the bibliography con­

tained numerous recommendations for both noninvasive human studies


and 	 invasive animal studies that would enable a basic understanding


of the mechanisms of cardiovascular adaption to zero-g.


Three primary areas were emphasized for detailed future space


flight experimentation:


1) 	 Altered vascular flow, volume, pressure relationships in


zero-g;


2) 	 Presence or absence of a compensatory body fluid redistri­

bution mechanism;


3) 	 Cardiovascular regulatory responses to exercise in zero-g.


During the process of instrumentation selection, it is evident 
that certain techniques and instrumentation applicable to humans


are 	 also applicable to animals. The use of an acceptable number of


implanted devices in any animal must also be considered since this


will ultimately be determined by the experiment objectives and the


principal investigator. Furthermore, for certain measurements such


as pressure or flow, several alternative methods are available, in­

cluding both invasive as well as noninvasive devices. It is fur­

ther assumed that invasive devices will be surgically implanted


duriig the preflight period. Still another major consideration is


cost. Where appropriate, instrumentation successfully employed in


previous space missions should receive full consideration for fu­

ture Shuttle/Spacelab missions. Typical examples would be the


Skylab blood and.urine collection equipment.
 

Common operations research equipment (CORE) must also be con­

sidered in the selection. CORE, as summarized 'in the appendix, was


developed by NASA with the support of industry and represents the


basic hardware complement of a general life sciences laboratory.


The equipment items were derived from a variety of sources that


included off-the-shelf Skylab, SRT, new developments, and Spacelab.


Off-the-shelf items will require modifications for the Shuttle en­

vironment but are generally commercially available. An example of


the use of CORE is as follows. For the potential cardiovascular


studies, such as the investigation of the Gauer-Henry reflex, the


hemotology/urology kits, the freezers, and the centrifuge CORE


equipment would be required.
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Still another consideration is the class of life sciences


laboratory (or payload) under consideration. A number of these


are categorized as being carry-on laboratories, minilaboratories,


or dedicated laboratories.


All of these factors will ultimately have to be considered in


the selection of cardiovascular deconditioning assessment hardware.


Furthermore, several advanced technology concepts will require ad­

ditional laboratory development and testing if they are to be ready


for Shuttle. These are discussed in the remainder of this chapter.


Flow and Pressure Measurement


The following instrumentation review includes several of the


classical techniques for information purposes only. Table XVIII


summarizes the blood flow measurement methods and is followed by


a discussion.


TABLE XVIII.- BLOOD FLOW MEASUREMENT METRODS


Extracorporeal measurement


Time accumulation


Orifice meter


Pitot-static tube with manometer


Rotameter


Vessel-invasive measurement


Hot-wire anemometer
 

Bristle flowmeter


Indicator dilution techniques
 

Sampling


Roentgen videodensitometry


Blood pressure techniques


Strain gage


Piezoelectric bimorph


Shock-excited tuning fork or crystal


Plethysmograph


Thermal flow-velocity transducer


Electromagnetic flowmeter


Ultrasonic techniques


Pulsed transit-time flowmeter


CW doppler flowmeter
 

Pulsed doppler flowmeter


Swept-frequency CW doppler flowmeter
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Extracorporeal measurement.- The following techniques are most


useful in combination with a heart-lung machine or dialysis, but


generally are not suitable for chronic use.


The accumulation method requires drawing off the flow into a 
graduated container and timing the accumulation. It is unrsffitfble 
for obvious reasons. 
The orifice meter requires that the blood flow through an iris


that distends more widely with greater volume flow rate. The area
 

of the orifice is proportional to the quantity of blood passing


through it in a given time. Conceivably,, this method could also


be employed intracorporeally but is still unsatisfactory because
 

the apparatus must come into contact with the blood to function.


The pitot-static tube used with a manometer is principally a


laboratory instrument. A pressure differential, created by the


moving blood stream, causes a displacement of the fluid in the U­

shaped manometer (fig. 5). The difference in the fluid levels is


an indication of the flow velocity. The apparatus is much too


large for implantation and is also position-sensitive.


Flo/


Vessel wall 
 
Static
pesure---* 	 Total 
pressure 
Figure 5.- Pitot-static tube with manometer.
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As shown in figure 6, the rotameter consists of a ball inside a


graduated tube. The ball rises inside the tapered tube until the


force of gravity just balances the force of the fluid as it rises.


The position of the ball thus corresponds to the volume flow rate.


It is position-sensitive, will not measure reverse flow, and is


unsuitable for implantation.


Flow


Flow


Figure 6.- Rotameter.


Vessel-invasive measurement.- The following techniques are


characterized by good measurement accuracy, but must be used in­

travenously to operate.


The hot-wire anemometer has an advantage in that it can be


made very small. It generally consists of a heating element sepa­

rated by a short distance from a temperature sensor. The blood is


heated slightly by the heating element. The temperature sensor


reads the highest temperature with zero flow. As velocity in­

creases, the temperature sensed decreases. The hot-wire anemometer


has bedn made in catheter and hypodermic needle tip configurations.


The bristle flowmeter consists of one or more "bristles" en­

cased in a cannulating probe and placed at an angle to the fluid


flow. As the flow increases the angle changes. The flow velocity


can be converted to an electrical signal by a strain gage coupled


to the bristles.


Indicator dilution techniques.- Indicator dilution begins with


the injection of an indicator into the bloodstream. The indicator


used and the techniques for extracting the desired information,


however, vary widely.
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The historical application of dye- or radioisotope-dilution


consists of injecting a quantity of the indicator and allowing the


indicator to become distributed according to the assumption that


the circulation is a steady-state system. Samples are withdrawn


and the concentration of indicator is measured. If the concentra­

tion in the area of interest is as expected the vessel is assumed


to be functional. The drawbacks are immediately apparent. No


information is obtained about the pulsatile nature of the flow.


A more recent method, which shows promise, involves the injec­

tion of a radiopaque contrast material and recording the roent­

genographic images on videotape. The videotape images may then be


analyzed on a per frame basis to extract the desired information.


In coordination with biplane angiograms to determine vessel geom­

etry, good quantitative data concerning pulsatile blood flow have


been obtained. Correction of the image for motion of the heart


and arteries is applied by a digital computer. At present this


technique requires a very complex instrumentation setup to reduce


the data and more-than-desirable exposure to X-rays by the patient


on a periodic basis.


Blood pressure techniques.- The simplest measurement of blood


pressure is palpation; however, statistical studies have shown that


measurement of blood pressure is not sufficient to guarantee that a


vessel is capable of transporting blood. The transducers discussed


here measure blood pressure externally and indirectly by sensing


the distension of the vessel due to the pulsatile pressure varia­

tions. None of these transducers used singly will provide the re­

quired flow information. However, by using them in pairs, located


axially from each other, some valid flow information can be obtain­

ed. As the pressure pulse propagates along a functioning artery,
 

the vessel distends at the site of the proximal transducer slightly


before it distends where the distal transducer is situated. The


waveforms from the sensors will therefore differe in phase. All


parts of the vessel will distend at nearly the same time and the


phase shift at the sensors will be absent. Phase shift depends on


flow direction, which satisfies another of the system requirements.


Because these methods are indirect, the output must be correlated


with an accurate temporary sensor during surgery. Moreover a change


in elasticity of the vessel wall with time could invalidate the cal­

ibration.


The strain gage is a device that changes resistance when it


is stretched. The resistance change can be converted to a modu­

lating voltage or current for transmission out of the body.
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The piezoelectric bimorph consists of two piezoelectric crys­

tals cemented together so one crystal expands and the other con­
tracts if the assembly is bent. If the bimorph is attached to a


clamp that clamps lightly around the vessel as in figure 7, the


expansion and contraction of the vessel will cause the bimorph


to produce a potential difference between its crystals. The elec­

trical output can be processed to measure the distension of the


vessel.


Piezoelectric


bimorphs


Figure 7.- Piezoelectric bimorph transducer.


Possibly the simplest system for transporting information about


an individual blood vessel out of the body is the ultrasonic tun­

ing fork or crystal. The distension of the vessel wall is used to


shock-excite a tuning fork or piezoelectric crystal. The crystal


will continue to oscillate at its resonant frequency. Figure 8


shows the system and its output, a damped oscillatory waveform.


The information content is restricted to the peak of the pressure


pulse, but two of these sensors located axially could provide a


qualitative indication of flow in the vessel.


Operation of the plethysmograph is based on the higher conduc­

tivity of blood than most other body tissues. As the systolic


pressure wave propagates through the arteries, they distend at.the


expense of surrounding tissue and the conductivity momentarily.


rises. In the implanted version, the plethysmograph applies a


constant high-frequency current to electrodes emplaced on opposite
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Figure 8.- Shock-excited resonant mechanical transducer.


sides of the vessel. As the cdnductivity changes, the voltage


across the electrodes changes., This voltage change is the sensor


output and is often attributed to blood flow. However, like the 
other techniques discussed, the principal parameter sensed is the 
distension of the vessel due to pressure.


Thermal flow-velocity transducer.- Figure 9 shows the "Thermo­
Stri1uhr."-Radio frequency power is applied to the capacitor plates 
on opposite sides of the vessel. The RF heats the blood between


the plates and the temperature differential measured by the thermo­
couples provides a voltage output. The slower-the flow, the more


the blood heats up and an increased voltage is obtained at the out­

put. This transducer is also sensitive to direction of flow. The 
system has been used to measure flow rates from 10 to 300 in/mn; 
however, the response is only marginal for observing pulsatile flow.


Electromagnetic flowmeters.- The EM flowmeter shown in figure


10 Es oie oftheoldestand most widely used sensors of blood 
volume flow rate. An alternating magnetic field is applied to pole 
pieces on opposite sides of the vessel. A magnetic field at right 
angles to the flow is produced. Blood flowing through the vessel 
cuts the lines of force and generates a voltage that is picked up by


electrodes on the vessel walls. The magnitude of the sensed vol­

tage is directly and linearly proportional to the volume flow rate.
 

The instrument is also sensitive to direction. Unfortunately, the 
EM flowmeter is sensitive to a number of errors that decrease its 
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Figure 9.- "Thermo-Stromuhr" transducer.


Electromagnetic E


E 
Figure 10.- Electromagnetic flowmeter.
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usefulness, e.g., the electrode circuits can act as a transformer


secondary with respect to the strong field applied by the electro­

magnet. This action produces extraneous signals that alter the


desired blood flow signals. The instrument is also difficult to


calibrate for zero flow. Another problem is poor reliability of 
the electrode contact with the vessel wall. F-inally, the electro­

magnet requires more power than is desirable. Thus, despite its


potential ability to yield the most accurate data for pulsatile


blood volume flow, it must be considered a poor candidate for im­

plantation.


Ultrasonic techniques.- Several distinct blood velocity tech­

niques employingiIt-rasound (high-frequency mechanical waves) have


been developed. They all have in common the use of piezoelectric


transmitters to transform an RF signal to a mechanical vibration


and a receiver to perform the reverse function. They have the


additional advantage of requiring no electrical contact with the


vessel, thus eliminating a potential source of artifacts. They


can also be made quite small and their power and circuitry re­

quirements are also less than for most other sensors. The primary


drawback of the ultrasonic systems is that they are sensitive to


flow velocity rather than to volume flow rate. Volume flow rate
 

can be determined with reasonable accuracy with knowledge of the


vessel diameter. Pitfalls associated with their use have been


discussed by Flax et al. (1973).


As shown in figure 11, the pulsed sonic flowmeter employs two


piezoelectric crystals (usually barium titanate) facing each other


diagonally across the blood vessel. The crystals serve alternately
 

as transmitter and receiver. A pulse from one crystal is sent


across the vessel lumen to the receiver. The transit time is mea­

sured. Then the process is reversed and a pulse from the second


crystal is sent-to the first. The difference in transit times is


a measure of flow in the vessel, being zero for zero-flow velocity.


Barium titanate


,crystals
Flow


Figure I.t.-Pulsed-ultrasonic transit time flowmeter.
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Transit time is longer upstream than downstream. The system re­

quires little power and is sensitive to direction of flow. A


major disadvantage is that the crystals, must be widely separated
 

(2 cm or more) for low flow rates, making the transducer somewhat


larger than desirable for many applications.


Doppler flowmeters operate on the principle that ultrasound.


waves are back-scattered from moving blood cells. Figure 12 illus­

trates the transducer arrangement. The transmitter emits a con­

tinuous wave of ultrasound energy into the vessel at an angle,


usually about 45 deg. A receiver crystal located diametrically


opposite the transmitter and aimed toward the vessel lumen at the


same angle picks up the reflected energy. Some of the transmitted


ultrasound reaches the receiver crystal directly and is, in fact,


much greater in amplitude than the back-scattered ultrasound.


Back-scattered energy from stationary cells comes to the receiver


exactly at the transmitted frequency and is "swamped out" by the


large direct component. But reflections from moving cells arrive


at a higher or lower frequency due to the Doppler effect and fre­

quency-modulate the signal at the receiver crystal. Due to the


mixing effect of the direct and reflected energy, sum and differ­

ence frequencies are also produced. The difference frequency con­

sists of the modulation only, which is an audio frequency. The 
audio frequency can be amplified and used to produce an output.


Unfortunately, this directly converted waveform cannot distinguish
 

the direction of flow -- it -responds identically to flow in both


directions. Therefore, the ultrasound frequency at the receiver


crystal is sometimes processed by other means to retain the direc­

tionality information. Doppler flowmeters normally operate between


2 and 10 MHz. At these frequencies the receiver signal may be am­

plified and transmitted out of the body without further frequency
 

Transmitter crystal


/ Receiver crysta!
 

Figure 12.- CW Doppler flowmeter. 
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conversions. It can also be made small enough for implantation in


very tight areas. It is therefore a high-ranking candidate for use


in an experimental system.


Another ultrasound technique uses two crystals diagonaily but 
asymmetrically opposite across the vessel lumen as in figure 13. 
The barium titanate crystals are excited simultaneously in phase 
opposition by a continuous wave signal at 5 MHz. Thus each crystal 
acts as a transmitter and receiver at the same time. With no flow, 
the signal on each crystal is identical -- the sum of its own ex­
citation signal, the direct received signal, and reflections from 
stationary objects like the vessel wall. These identical signals 
are canceled at the input to a differential amplifier. When blood 
is flowing in the vessel, however, the signals passing through the 
lumen are phase-modulated, the upstream signal now being different 
in phase than the downstream signal. These signals are no longer 
canceled at the amplifier input and an output signal is produced. 
The interferometer is an interesting concept but the system balance 
is quite critical and the baseline may exhibit serious instability 
over a period of time. Another serious disadvantage is that the 
asymmetrical design makes the probe even larger than that of the 
pulsed-sonic flowneter.


Two other techniques for Doppler flowmeters are deserving of


mention although the additional information to be gained from them 
probably does not justify the increase in system complexity in this 
instance. Both are used to obtain a velocity profile across the


Crystal 2


(0 deg) - (180 deg) Ex X 
 
'Figure 13.- Ultrasonic interferometric blood flowmeter. 
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vessel lumen. The first is a pulsed-Doppler single-crystal tran­

ceiver. A pulse of ultrasound energy is directed into the vessel


at a 45-deg angle. The reflected energy is received at the same


crystal after a transit time depending on the distance to the crys­

tal -- very similar to a pulse radar system. A range gating system


is used to divide the vessel into range intervals. A cancellation


circuit is used to eliminate echoes that return at exactly the


taansmitted frequency and represent static elements. Doppler­

shifted moving elements are processed within their range intervals.


In this manner, using the information received for each range in­

terval, a velocity profile across the lumen is developed.


Pulsed Doppler catheter tip flowmeters that measure instan­

taneous flows within the vessel have been reported (Hartley and


Cole, 1974; Pardue et al., 1975).


A second method uses a frequency-modulated, CW Doppler signal.


The transducer is identical to that shown in figure 12 but is ex­

cited by a sawtooth frequency sweep. The frequency difference
 

reflected onto the receiver crystal is now a combination of the


range of the reflector and its velocity. By comparing the instan­

taneous transmitter and receiver signals, a velocity profile can


be developed as in the pulsed-Doppler system.
 

Power Sources 
Sources of power for devices implanted within the body fall


within three distinct categories -- implanted storage sources,


biological energy sources, and extracorporeal energy sources as


illustrated in Table XVIII.


TABLE XIX.- POWER SOURCES FOR IMPLANTED SENSORS


Implanted stored-energy sources


Electrochemical power sources


Pacemaker cells.


Solid-electrolyte batteries


Nuclear power sources


Biological energy sources


Biochemical energy sources


Biofuel cells


Ionic concentration cells


Biogalvanic cells


Biomechanical energy sources


Extracorporeal energy sources
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Implanted storage sources.- This category includes electro­

chemialaTd and-ffiicddr p-We- sources housed in sealed containers


and surgically implanted. At present these energy supplies are


used primarily to power cardiac pacemakers.


Although considerable research is in progress, the field of


implantable cells is incredibly small. The most widely used pace­

maker battery is the Mallory R3-1, a 1.35-V, 1-A-h cell. Although


designed for a three- to four-year lifetime at currents in the 30­

to 40-pA range, most are replaced at around two years due to losses


within the cells. Several batteries with a solid electrolyte such


as lithium-iodine, silver-iodine and lithium-iodide salt have been


proposed and evaluated. However, these experimental cells have not 
proved to be significantly better than the RM-1. It is possible 
that the zinc-mercury P14-1 would be acceptable for intermittent 
use if it were turned on only when measurents were taken. Magnetic 
reed switches have been successfully implanted and used this way. 
The Model 50 Betacel made by McDonnell Douglas Astronautics is


a promethium-fueled nuclear battery. -It has a volume of 1.8 cc


(about half the size of the zinc-mercuric oxide cell discussed


earlier). When new, the battery has a terminal voltage of 2.0 V 
and a short-circuit current of 42 pA. Promethium 147.has a 2.63­
year half-life and the battery capacity decreases accordingly, 
whether used or not. 
Biological energy sources.- The search for ways to produce


electrical energy from processes within the body has produced


some interesting results. The experiments have been frustrated,


however, by the cyclical nature of body functions and the mecha­

nisms by which the human organism tends to surround any foreign


object with a mass of tissue. Both chemical and mechanical methods


have been attempted.
 

Biofuel cells make use of the body's metabolism in an oxidation­
reduction reaction. An example biofuel cell uses platinum black


electrodes bonded to a tantalum mesh. The electrodes act as a


catalyst to oxidize glucose at the anode and reduce oxygen at 
the cathode. In vivo experiments showed that the cell worked, but 
only for a few days before the catylitic action at the anode was 
poisoned by proteins. 

Ionic concentration cells have also been tried. These cells


depend on different ionic concentrations in different areas of


the body. So far the differences in concentrations have been


found to be too small or the fluctuations too large for a


practical cell to be constructed.
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Biogalvanic sources have met with.some moderate success. Gal­

vanic pairs of metal electrodes are used with body fluids serving


as the electrolyte. As in electrochemical batteries, the elec­

trodes and the electrolyte are consumed in the reaction, a process


that limits the useful life.


The growth of tissue can also render the cells useless in a


short time although inert materials with selective permeability


have had some effect in prolonging the cell life as well as pre­

venting pathological reaction in the tissues.
 

A converter similar to the bimorph pressure transducer in figure


7 can produce electric power. If a larger version is placed on the


aorta, the more active pulsing could conceivably generate enough


power to operate a blood flow transducer system. Unfortunately,


the constant flexing of a sufficiently large and thick crystal


would lead to fatigue failure in a relatively short time. In addi­

tion, the defensive tissue growth would tend to reduce the output.


Extracorporeal energy sources.- By transporting energy into the


body only when needed, an extracorporeal power source overcomes the


difficulties inherent in using implanted sources To maintain iso­

lation, dc current paths through the body and RF induction methods


are normally used. A flat external coil is placed over the area of 
a similar implanted coil as in figure 14. RF energy is coupled


from the external primary coil to the internal secondary through


mutual inductance. The secondary energy is then rectified and


-filtered to produce the dc operating voltages for he implanted


flowmeter sensor. A storage capacitorwould normally be used to


provide continuous operation during short interruptions of the in­

put power. The transfer of sufficient energy into the 1ody to


power the sensor and electronics is no particular problem. It is


anticipated that the total power requirement will be considerably


under 1W. Power transfer of 1000 W into the body of a dog has


been attained with no apparent tissue damage and only a 70F dm­

perature rise immediately beneath the transmitter coil after 90


minutes of operation. The primary drawback -- and the point that


should receive considerable attention -- is the'possibility of inter­

ference with other instrumentation. [A thorough review of power


sources for bioinstrumentation is given by Fryer (1970; 1974)].


Telemetry Technology
 

Implanted telemetry transmitters have been in use for many


years and the technology is well developed. The most coman appli­

cation has been for remote monitoring of physiological parameters


of unrestrained animals. The primary considerations are range,


choice of frequencies, multiplexing, and special considerations
 

for implanted transmitters such as tissue damage and ,interference


with other instrumentation. The receiving range varies from just
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Figure 14.- Transcutaneous induction energy transfer.


outside the skin to many miles, depending on transmitter power,


frequency, modulation method, and antennas. Frequency modulation


is often employed, in part because it is simple to generate, but


mostly because it maintains better data fidelity than other simple
 

systems such as amplitude modulation. The choice of frequencies


is usually-in-the VHF region -- 30 to 300 MHz. It has been com­
mon practice to place the telemetry transmitter between 88 and 
108 MHz and use a high-quality standard FM receiver. The Federal 
Communications Commission has authorized frequencies in the 460-MHz 
band for medical telemetry but the intent is for telemetry from an 
emergency vehicle to the hospital emergency room rather than from 
an implanted transmitter to the laboratory equipment. The fre­
quencies chosen for flowmeter telemetry will depend on the trans­
ducer usea. For example, when using a CW Doppler sensor it would 
simplify the implanted circuitry to use the 5- to 10-MHz excitation 
frequency as the telemetry frequency as well. 
Multichannel telemetry systems [Biotelemetry, Vol 3 (1): 1-64,


(1976), Fryer (1970) and Sandier, et al., (1972)] are cormonly em­

ployed when the use of more than one sensor is desired. It is


not economical to have a separate transmitter for each sensor.


Most biological parameters are in the audio to subaudio frequency


range. These fairly low frequency signals easily permit the out­

put of several sensors to time-share the same transmitter carrier
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by sampling each sensor output in turn. The reverse process re­

stores the original information at the telemetry receiver. The


advent of CMOS integrated circuits now makes possible a multi­

channel system that takes very little more power than a single­

channel system.


Cardiovascular Noninvasive Instrumentation


Cardiovascular deconditioning assessment will require a wide'


range of noninvasive instrumentation such as that illustrated in


table XX. This table is intended to provide the reader with a


brief summary of applicable existing cardiovascular performance


monitoring hardware.


Technology Status


Ultrasound considerations.- The use of ultrasound devices in


cardiovascular measurement has greatly increased in the last decade


and now holds great promise in many areas of diagnosis and monitor­

ing. Although some of the major advances do not seem closely re­

lated to space medicine and cardiovascular measurements, many do.


Two major technology areas germane to these areas,of interest are


organ system visualization, in this case, echocardiography re­

lating to the heart and great arteries and measurements of hemo­

dynamics related to heart output and activity, and the peripheral


vessel system.


The literature covering even these restricted fields has become


voluminous; however, several excellent review works are available


[Popp & Harrison, 1974; Goldberg, 1973; Harrison, Sandler and Miller


(Eds), 1975] and the material covered in them will not be'repeated


in detail here.


The key features of the ultrasound technique that make it


attractive are the options of using it invasively or noninvasively,


safety, comfort, and feasibility of continuous measurements of


mobile subjects. The equipment, including the data handling elec­

tronics, can be small, at least for peripheral vessel monitoring


systems. Transducers of barium titanate and lead titanate zircon­

ate, as well as others, are typically operated at 2 to 8 MHz and


have diameters of 2.5 to 10 mm.


Echocardiography.- Echocardiography has been used primarily to


detect such abnormalities as aneurysms or occlusions in the vessels


and pericardial effusions, valve malfunctions, and heart tumors.


Left ventricular stroke volume, ventricular wall thickness, and


wall motion can also be determined and, with two-dimensional trans­

ducer arrays, a three-dimensional image of the heart is feasible


(Beaver, et al., 1975).
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TABLE XX.- CARDIOVASCULAR SYSTEM PERFORMAICE MONITORING HARDWARE


of 
Number Identification Paentee(s) Measured Physical Principle Used Restrictions on Use Development State Remarks 
t eetrseardiograph Time history of mst.­
lar and electrical 
events during heart 
beats 
Time histories of alc- Clinlc or labs re­
trical potentials on quired, patients' 
surface points of the- covemnts limited by 
rot indicatedesired facilities 
High. 
able 
readily avail- Highly standardized 
methods and interpre­
ration 
paraeteors 
2 Vectorcardiograph Time hlsory of -mcc­
lar and electrical 
0me additional cle­
trode allows 3-dimen-
Clinics 
quired, 
or labs re­
patients' 
High. ore specialized 
than item I 
May different gnstr ­
mearts, needs standard­
events 
beas 
during heart sional vectorial in­
repretr ion of etem­
coveeants limited 
facilities 
by ization 
trical potentials 
3 Sonocardiograph 2-diensional outline 
of heart and 3-dinen­
s.isal picture .f aide 
Sonically senses heart Clinics or labs re- , 
with matrix of sensors quired, display on OPT 
at 40 fr.esse pat eond 
Developmental, prote­
type built and tested 
at ASA-At 
Can be used for heart 
stroke volume measure­
at 
heart 
4 Ler body negative Cardiovascular capa- Size (volm) of loser Specialized setup, de- Developed especially Cambe used both on 
pressure device bility as a function body ar negative pres- cads total patient for Skylab ground and in large 
of tie spent in zero- sures indicates rdio- availability during spacecraft 
genvironment vascular capability rest 
5 Wearable blood pre- Pressure vs time with Tiny silicon diaphragms Unrestricted Developmental pr.o- Development continuing 
sure recording system suitable superficial with diffused boron re- types are in being a Stanford Research 
mrieiscaors Institutesense artery 
through skin 
6 Wearable MCGrecord- Sane as item 1, usual- Same as item 1 largely unrestricted, High. developed for Self-contained recorder 
ins syaon. 	 ly with reduced number patient se carry beth civilian and .rtelece try required, 
of leads end cape- instrmentation space environment can be combined with 
bilities otherinstruments 
7 	 Apex cardiograph Left ventricular pres- Microphone records Patient in specified High. orespecial- ,osstadardized, easily 
(k .n.oardiograph)vs aisoN. displacement. as position, lying do iced than . In.a1 assembledue 	 hest 
maximum impulse leca­
tion free0 1 to 20 0 
H.

a Pledoeectric pulse Arterial pulse Piezoelectric crystals Practically none High Readily fabricated, 
pickup respond to pressure inexpensive 
changes 
9 	 Phonoarteriograph See item 11 below 
10 See item 11 balo 	 Heptic (tracings) 
11 Echoecodiograph 	 actual meious of Sound waves are reflee- Clinics or labs re- pige.h.atopesve Considerable technical 
heart components, e , ted by body components quired skill required for 
anterior mitral valve adequate tests 
leaflet


12 Cineflaorograph Fuceionigl of pro- Direct visualization Used only for special- High, cine frame rates Image Intensifier tubes 
stbetiether valves end iephoacaraphy by ised studies oa pros- wp O180 pe secod .sed 
nans of -ray fleoro- therie valves 
&copy 
13 Radionulide imaging 	 Cross heart component Concentrations of law resolution in soce- Developmsntal Pgtremely high data 
dimensions, bleod flow mualeldes are ShOVe by tillrion camera limits cares aallble 
volumes, etc scintillation cameras use to gross measure­
ments 
14 	 Impedance cardiograph Volumeric blood flow 	 Thoracic impedance of Clinics or labs me- Develop=ental Can be combined with 
20 to IC0 10 a.n be quired ECC 
calibrated in terms of 
blood flow 
15 Cardiotachometer Heart beat rate 	 Peasures time between See items I and 6 High Incorporated in items 
beats 1.2,4. 7. 8. 9. 10. 
12, 13, etc


48 
OF 	 THERE.PRODUCIBILITY 
OBIGINAjL PAGE IS POOR 
Miniaturized equipment does not seem essential for echocardic­

graphy since displays for A and B scans are ordinarily required in


the form of cathode ray tubes, which are quite bulky. While there


is no fundamental reason why the transducers and electronics


associated with driving and data handling cannot be miniaturized,


the nature of usage of echocardiography would-seem to rule out the


sensibility of such miniaturization. Such reviews of echocardio­

graphy Are available (Popp and Harrison, 1974; Popp, 1975).,


Scanning can be accomplished mechanically by moving,the ,trans­

ducer. Also acoustic or electric scanning is possible by focusing a


two-dimensional array of transducers with an electronic array of


charge coupled device (CCD) circuits (Beaver, et al., 1975). 1


Miniature two-dimensional arrays developed by several workers


(Bom, et al., Beaver, et al., 1975; Kisslo, et al., 1975) permit


rather accurate visualization of organs with stationary trans


ducers. One- and two-dimensional acoustical imaging devices pro­

viding 2-mm resolution at 20 cm and a frequency of 2.25 NMz.have


been described (Traser et al., 1974; Kino, 1974). These devices,


may have application to biomedical measurements, although they were


not designed specifically for this purpose. Surface acoustical wave


techniques are used to scan optical or acoustical images and for


electronic focusing of acoustical images.


Doppler ultrasonic cardiovascular measurements.- Doppler tech­

niques permit ultrasound to be used.for either diagnosis or monitor­

ing of the heart or vessels. A splendid review of basic concepts,


techniques, and some of the problems of Doppler measurements has


been given by Gill, et al., (1975). Monitoring in space medicine


has received-more emphasis than diagnosis, and this trend will be


reflected in the following discussion.
 

Heart wall motion can be detected by continuously monitored


Doppler techniques; Esophageal probes and implanted probes can,,


continuously monitor flow rates and cross sections of the vessels


approximate to the heart. These techniques, however, seem likely


to be limited to experimental animals or human surrogates in space


in spite of the fact that some of the best results in measuring


blood flow by Doppler have been obtained by invasive techniques.


Invasive measurements on the aorta have been quite successful,
 

either with or without percutaneous connections, the latter permit­

ting subjects to engage in activity.regimes (Foletta, et al., 1974).


The fluid-mechanical aspects of blood flow haveebeen charac­

terized by Talbot and Berger (1974), showing clear relationships


between blood pressure and velocities at various sites along the


arteries.
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Theoretical analyses of both CW and pulsed Doppler flowmeters


published by several workers (e.g., Brody and Mendl, 1974; Gill,


et al., 1975; Hottinger and Meindl, 1974; McLeod, 1974) have pro­

vided a basis for sophisticated digital data handling techniques.


Velocity profiles across vessel sections are being characterized


by McLeod of Colorado State University using his multichannel Dop­

pler flowmeter techniques (McLeod, 1974; McLeod, et al., 1974).


They provide a potential basis for estimating total blood flow from


average velocity and vessel diameter, a much simpler task electron­

ically than measuring velocities of the total vessel cross section.


Foletta, et al., (1974) pointed out that only a pulsed Doppler


shift is capable of measuring blood flow from one side of a vessel.


This seems to be the most likely candidate noninvasive technique


for man in space. Noise problems are severe, however, and the


signals will require extensive processing, which is not necessarily


prohibitive if done digitally.


Doppler techniques employing wideband transmitted frequencies


have been recently described and analyzed. Better range and reso­

lution are claimed using these techniques than are available with


the usual pulsed deterministic transmitted signal Jethwa and


Olinger, 1975; Newhouse, et al., 1976).


Vessel wall motion can be parametrically related to blood pres­

sures. A 55 dB SIN ratio can be obtained from vessel walls compared


with erythrocyte back-scattering. A blood pressure indicator em­

bodying Doppler ultrasonics, a stored parametric relationship be­

tween brachial and radial artery parameters (for a given subject),


and a microprocessor is based on this principle. This work is be­

ing done by Martin Marietta personnel at the Denver Division.


Computer processing.- Considerable work has been done on com­
puter processing of data produced by ultrasound. Most of this 
work has been directed at echocardiograph images of the heart and 
great vessels (Hirsch, et al., 1973; Saunders and Harrison, 1975)


but some work has also been done on data derived from smaller


vessels, the latter unpublished work by the Martin Marietta


Corporation. One of the key technology items pacing the use of


computers for cardiovascular parameter analysis is the development


of hardware preprocessors to effectively detect the onset (usually


a rising wavefront) of a cardiac event. Some of the successes of


computer processing of biomedical images have been reviewed by


Preston (1976) and the future discussed. The advent of micro­

processors at low cost along with substantial commitments from their


manufacturers to provide software and operating systems will un­

doubtedly enhance the widespread use of digital computers in cardio­

vascular measurement systems.
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Gas analysis.- Sodal and coworkers at the University of


Colorado have had considerable success in using mass sp-tf6scopy


for monitoring the pulmonary and cardiovascular parameters listed


in table XXI. 
TABLE XXI.- MASS SPECTROSCOPY PARAMETERS 
1) 	 Standard pulmonary functions; 
a) 	 Vital capacity, 

b) 	 Forced vital capacity,


c) 	 Maximum breathing capacity,


d) 	 Lung volumes,


e) 	 Closing volumes,


f) 	 Occlusion pressures,
 

g) 	 Flow volume curves;


2) 	 Hypoxic and hypercapnic ventilatory drive;


3) 	 Oxygen uptake;
 

4) 	 CO2 production;


5) 	 Cardiac output (noninvasively, gaseous method);


6) 	 Lung water;


7) 	 Arterial P02 and PC0 2 (noninvasive);


8) 	 Arterial POZ-PCO2 and arterial 02 and CO2 content


on drawn blood samples;


9) 	 Distribution of V/Q ratios (method of Wagner and


West).


A miniature, fully computerized respiratory mass spectrometer


has been developed in their laboratories over the past several


years. This instrument is now completed to the point where it
 

could perform the first five meastrements indicated in Table XXI.


Preliminary work has been conducted at this time to adapt this in­

strument to blood gas analysis, both measurement of content and gas


tensions. This would make possible the use of the same instrument


for measurements 6 through 8 in the same table.


The 	 capability'for noninvasively measuring arterial P02 and


PCO2 depends on transcutaneous outgassing. Previous work has been


accomplished in Germany and England, but the measurements 'suffered


fr6m rather wide variations (Sodal, personal communications). The


method used by Sodal, et al., is to heat the skin to 42 to 430C,


pull a vacuum against the skin across a few mil diameter capillary,


and transfer a gas sample to the spectrometer inlet. The inlet


system uses a servo-driven piezoelectric sapphire against a steel


inlet valve with a sampling time per gas of 1-ms and a 30-ms set­

tling time. A new ionizer has also been designed to permit fast


response time and high efficiency.
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The direct inlet system and ionizer are the prominent features


of this 25-lb instrument, which can follow concentration profiles


of all gas components during the entire breathing cycle. Several


gas components, plus water vapor, can be monitored simultaneously.


Cardiac dimension measurement.- Two methods of cardiac measure­

ment have been reviewed: (1) the method in which dimensions are


evaluated from cineradiograms of cardiac chamber in which silver­

tantalum clips have been sutured to the external surface of the


ventricles, and (2) a noninvasive method in which echocardiograms


are made with the use of ultrasonic transducers.


The first method (Harrison, et al., 1963) is implemented with


silver-tantalum clips, which are nonreactive. These clips are


sutured to three points on each cardiac chamber, forming a tri­

angle on the anterior surface of the right ventricle with the apex


of the triangle in the right ventricular outflow tract. Two clips


are placed along the lateral surface of the left ventricle, one


near its apex and the other near its base. The third clip is su­

tured to a point on the interior-posterior aspect of this chamber.


Films are exposed in the frontal projection with a Picker image


orthicon utilizing a 16-mm camera at 30 exposures per second. To


detect any motion in the X-ray field, small metal markers were


placed on the anterior and posterior strfaces of the chest wall.


The individual frames of the films were correlated with specific


points in the cardiac cycle with a mechanical indicator, which was


triggered by the R-wave of the electrocardiogram. This permits


precise correlation of each frame of the cineradiogram with the data


recorded on the photographic recorder. The processed films are pro­

jected on a screen or a specially constructed cineradiographic ana­

lyzer, and the distances between clips on the magnified image were


measured to-the nearest millimeter. Measurements are reproducible


to within 1.5%.


Recently a light-pen computer processing combination has been


applied to angiograms for the determination of left ventricular


volume (Alderman, et al., 1973). This method eliminates the te­

dious hand calculation of volume.


Another method involves the use of ultrasonic transducers di­

rected from different orientations. The echoes from the cardiac


chamber define the structure and thence the dimensions. Techniques


to direct the ultrasonic transducers to a common location and there­

by a common point of reference have been reported (Popp, et al.,


1975; Popp, Brown and Harrison, 1975). The problem with this


technique is repeatability of results. There is no standard inter­

space in the cardiac chamber, that is, standardization from one sub­

ject to another.
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These limitations on ultrasonic transducers are not a limiting


factor for the space experiment in which the subjects used cin 5"e 
clinically evaluated prior to the space activity. Standard­

ization appears to be achievable and ultrasonic methods of dimen­

sioning by measuring echoes appears to be a practical noninvasive


method.


Blood pressure and flow.- Measurements of blood pressure and


flow include the following parameters:


1) Velocity of blood in the vessel;


2) Changes in blood velocity;


3) Volume of blood flow;


4) Systolic and diastolic blood pressure.


The various instruments available or under development are sum­

marized in table XVIII, and can be categorized as follows:


1) Noninvasive, suitable for space flight;


2) Invasive, suitable for space flight;


3) Invasive, not suitable for space flight.


Some of the instruments or techniques are largely of historical


interest (e:g., manometers) described in tests such as Ruch and


Patton (1965) and would not logically seem to be candidates for


space use. Most of the invasive techniques are also well-covered


in the older literature but are included here for the sake of com­

pleteness and their utility in human surrogates and other test


animals.


The techniques of greatest interest at present are noninvasive


and are the subject of considerable current research. The venous


occlusion plethysmograph has been long known as a tool for esti­

mating blood flow, and modern electronics have been used in recent
 

developmental work on automating the cuff plethysmograph and identi­

fying the associated Korotkov sounds for blood pressure measurements


(Golden et al., 1974; Wolthuis, et al., 1974). Perhaps the great­

est current interest centers around the use of ultrasound for both


flow and pressure measurements because of the small size, wide


variety of possible configurations, and the resulting electrical


signals, the nature of which enables the application of digital


processing. The advent of large-scale integrated circuits and


microprocessors will almost certainly result in effective non­

invasive peripheral cardiovascular measuring devices in the near


future.
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While there are apparently no commercially available ultra­

sound blood flow or pressure devices suitable for space use,


several active research projects show considerable promise:


1) McLeod (McLeod et al., 1974) is establishing velocity 
profiles across vessel cross sections. In healthy sub­
jects, parametric relationships can be established 
whereby vessel cross-sectional area and direct average 
velocity measurements can probably yield quite accurate 
estimates of flow; 
2) Polhemus (unpublished) is using parametric relations be­
tween radial artery wall velocity at systole and measured 
systolic and diastolic pressures at the brachial artery 
to estimate blood pressure parameters. Additional mea­
surement of artery diameter will permit estimates of 
flow when coupled with clinical characterization of a 
subject; 
3) Under contract to NASA-ARC, McLeod (unpublished) is com­
pleting a system that uses two transducers oriented up­
stream along the vessel. Axial and radial components 
are measured simultaneously and flow direction is estab­
lished unambiguously. Vessel diameter is estimated by 
low-frequency high-energy returns from the vessel walls. 
This method should provide good estimates of blood flow; 
4) Baker, et al. (unpublished)-uses a rotating pulsed 
Doppler scanner plus a stationary pulsed Doppler in an 
imaging system. The transducer position is established 
by use of a sonic microphone and spark gap. The vessel 
center is located at two positions several cm apart to 
determine the angle relative to the scanner. Information 
is obtained on vessel morphology, as well as arthero­
scloratic plaque, etc; 
5) Meindl and coworkers have reported a number of Doppler 
flowmeters, so far restricted in practice to the great 
vessels. Some of the most interesting are the "angle­
free" systems (Hottinger and Meindl, 1974; Gill et al., 
1975) that give estimates of blood flow independent of 
lumen cross section, orientation, or velocity profile. 
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SUMMARY AND RECOMMENDATIONS


NASA has stated that the compensatory, adaptive processes


produced by space flight could possibly create significant dif­

ficulties during reentry and postreentry survival situations


and could pose problems for inflight emergencies and for long­

term readjustment to earth conditions.


The potential for determining basic mechanisms of cardio­

vascular system response to zero-g and applying this knowledge to


prevent or reduce orthostatic intolerance and other cardiovascular­

related effects during Shuttle flight, reentry, and flyback is


a necessary and important activity. Quantitative assessment of


the following observations is deemed necessary to fully understand


the short- and long-term effects of cardiovascular deconditioning


as a result of space flight:


1) 	 Shift in distribution of intravascular volume;


2) 	 Instability of cardiac electrical activity;


3) 	 Modification of integration and regulation pattern;


4) -Blood volume shifts during reentry;


5) 	 Orthostatic intolerance during tilt, LBNP, and centri­

fugation following flight or bed-rest exposure;


6) 	 Cellular alterations.


Human bed-rest studies should continue to receive heavy em­

phasis to arrive at criteria that will enable optimization of


crew performance, maximum safety, and candidate crew selection.


Recent positive indications of orthostatic countermeasures via


dietary techniques add further credulity to bed-rest studies.


Continued emphasis is required on techniques for observing the


time course of cardiac size, peripheral vascular compliance, and


flow distribution, both in an unstressed and stressed environ­

ment during the bed-rest studies.


Table XXII summarizes the desired observable along with can­

didate instrumentation requirements. These can readily be com­

pared to current NASA programs such as those tabulated in table
 

XXIII. Our study results indicate that the instrumentation listed


in table XXIV requires further development for future space flight.


However, increased emphasis should be given to the types of in­

strumentation and studies outlined in the following sections.
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TABLE XXIII- CARDIOVASCULAR PERFORMANCE AND 
DECONDITIONING ASSESSMENT


Observable 
 
1. 	 Fluid distribution changes 
 
and vascular compliiance 
 
2. 	 Orthostatic hypotension 
 
(fluid volumes, control and 
 
regulatory mechanisms) 
 
3. 	 Cardiopulmonary circulatory 
 
dynamics 
 
4. 	 Cardiac dimensional analysis 
 
5. 	 Indices of functional 
 
alterations


6. 	 Etiological mechanisms 
 
7. 	 Response to dynamic stress 
 
8. 	 Neurohumoral control of 
 
cardiovascular function 
 
9. 	 Cellular fine structures 
 
Assessment technique


Photoplethymograph


Limb plethysmograph


Drugs


Exercise program
 

Flow sensors


Biotelemetry systems


Vibration facility


Vibration transducer


Radioisotope equipment
 

Doppler ultrasonic flow sensor


Invasive flow transducers


Vasoactive drugs


Scanning echo device (3D)


Low-dose X-ray system


Multisensor transducer for wall motion


Apexcardiogram


Echocardiogram


Scintillation angiocardiogram


LBNP


Centrifuge


Echocardiography


Doppler transcutaneous flow sensors


Implanted pressure transducers
 

Implanted flow transducers


Implanted pacemakers


Implanted brain electrodes


Pharmacologic tests


Pharmacologic studies


Image enhancement techniques


Temperature transducer, implantable
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TABLE XXIII.- CARDIOVASCULAR PERFORMANCE AND 
 
Measurement objective(s) 
 
1 	 Measure change in body, fluid 
 
distribution, and vascular 
 
compliance for cardiovascular 
 
deconditioning detection 
 
2 	 Measure orthostatic 
 
hypotension processes 
 
3. 	 Determine effects of alter-

ations in preload and after-

load on ventricular function 
 
4. 	 Study circulatory dynamics, 
 
cardiovascular and pulmonary 
 
C
omputer study of clinical 
 
vectorcardiograms for early 
 
detection of CV disease 
 
6. 	 Evaluate indices of func-

tional alterations with 
 
deconditioning 
 
7. 	 Plethysmograph refinement 
 
8 	 Observe left ventricle via 
 
3D scan mechanization 
 
9. 	 Evaluate etiological 
 
mechanisms 
 
U'


Subject 
 
Human 
 
Human 
 
Human 
 
Human 
 
Human 
 
(clinical


use)


Human 
 
Human 
 
Human 
 
Huian 
 
(clinical 
use) 
 
DECONDITIONING ASSESSMENT


Observable(s) 
 
Limb compliance 
 
Volume 
 
Pressure 
 
I 
Fluid volumes 
 
Headward body fluid 
 
shifts 
 
Cardiac output 
 
Stroke volume 
 
Pulmonary and systemic 
 
circulation times 
 
Ventilation/perfusion 
 
ratios


Airway closing volumes


VCG parameters 
 
Precordial wall motion 
 
Systolic time intervals 
 
Pulse transmission time 
 
Limb circumference 
 
Left ventricular volume 
Cardiac output, X, etc 
Cardiac output 
Stroke volume 
Diastolic and systolic 
volumes 
 
Ejection fraction 
 
Left ventricular end-

diastolic pressure


Assessment technique 
 
Noncontact limb volume technique using 
 
photoelectric principle 
 
Assess role of angiotension It na 
 
control of blood pressure and in 
 
postural homeostasis


Use LBNP to reduce left ventricular 
 
preload 
 
Drug effects studies 
 
Radioisotope equipmenc 
 
Technitium 99 - CV circulatory 
 
dynamics 
 
Xenon 133 - Pulmonary circulatory 
 
dynamics


Computer analysis of vectorcardiograms 
 
Multisensor transducer for wall 
 
motion detection 
 
Assemble statistics for ST I


Use vasodilators and vasoconstrictors


Plethysmographic 
 
Echocardiography 
 
Apexcardiography 
 
Systolic time intervals 
 
Echocardiography 
Scintillation angiocardiology 
 
Compare above with invasive measure­
ment results


Equipment


Photoplethysmograph for limb circum­

ference measurement


tEMP


Centrifuge


LENP


Vectorcardiogram


LENP


Nieroprasaide intravenou infusion


Nitroglycerin sublingually and


intravenous infusion


Catheter probes, etc


LDNP


Tilt table 
Compare to ST I, echocardiography 
VCG, etc 
Vectorcardiograph


Multisensor transducer for wall


motion detection


Limb plethysmograph


Arm plethysmograph


Scanning echo device


ECG


Apexcardiograph


Echocardiograph


Scintillation angiocardiograph


Etc


0 TABLE XXIII.- CARDIOVASCULAR PERFORMANCE AND DECONDITIONING ASSESSMENT - Continued


Measurement bjective(s) Subject 
10. 	 Measure degraded responses Human and 
to exercise, +g acceleration, Animal 
 
and LBNP 
 
11. 	 Measure changes in orthostatic Human 
 
tolerance due to space flight 
 
12. 	 Hemodynamic measurements Human 
 
using ultrasonic techniques 
 
13 	 Bandwidth reduction via Human or 
 
compression of complex animals 
 
physiological system 
 
14. 	 Blood flow distribution via Animals 
 
ultrasonics for understanding 
 
CV adaptive processes 
 
15. 	 Animal studies of blood flow Animals 
 
16. 	 Study of neurohumoral control Animals 
 
of CV function 
 
17 	 CV response of primates to Animals 
 
orthostatic stresses 
 
Observable(s) 
 
Marked increases in 
 
coronary blood flow 
 
Mechanoreceptor 
 
stimulation response 
 
Orthostatic regulation 
 
Volume blood flow 
 
Velocity


Vessel dimensions 
EGG 
Pressure Process and 
Flow ( condense 
DimensionI


Blood velocity profile 
 
and vessel cross-

sectional area 
 
Cardiac and peripheral 
 
vascular changes 
 
Coronary blood flow 
 
Intravascular


pressures


Cerebral, renal, and


splanrhuic blood


flow


Ventricular pressure 
 
Atrial pressure 
 
Cardiac dimensions 
 
Ventricular flow 
 
Ventricular wall 
 
thickness


Arterial flow 
 
Venous flow 
 
Assessment technique 
 
Bed-rest studies to determine cardiac 
 
function 
 
Invasive animal experiments 
 
Apply stress, i.e., selective 
 
stimulation of major cardiovascular 
 
mechanoreceptor subgroups and 
 
observe response 
 
Noninvasive Doppler ultrasonics 
 
Hardware development 
 
Use implantable flow system to measure 
 
Renal 
 
Coronary 
 
Intestinal 
 
Cerebral flow


Stress testing 
 
Vasoactive drugs 
 
Pharmacologic tests 
 
Provocative stimulation of critical 
 
central nervous system areas via 
 
radio telemetry techniques 
 
Measure arterial and/or venous flows 
 
in cerebral, renal, coronary, and 
 
nesenteric vascular beds 
 
Cardiac denervation (surgical and 
 
chemical)


Equipment


LUMP


Centrifuge


Echocardiograph


Doppler transcutaneous flow sensors


LBNP


Apply abdominal compression


Positive pressure breathing


Tilt table


Doppler ultrasonic flow system


Data 	compression techniques


Posttransmission reconstruction


Frequency filtering


Doppler telemetry system


Single crystal transducers


Transcutaneous arrays


Catheters


Implanted instrumentation


Centrifuge


LBNP


Transducers'(implaAted and


hardwired telemetry


LBNP


Implanted pacemakers


Brain electrodes


Tilt table


LBNP


Hardwire transducers with back­

pack 	 telemetry system


TABLE XXIII.- CARDIOVASCULAR PERFORMANCE AND DECONDITIONING ASSESSMENT - Concluded 
Measurement objective(s) Subject Observable(s) Assessment technique 	 Equipment 
18. Cellular consequences and Animals Cellular fine structures Compare cellular fine structure Centrifuge 
ultrastructural effects of effects (cardiac morphologic changes with phsiologic LBNP


CV deconditioning muscle) function Kosmos 75 and 76 animals


Measure norepinephrine Apply various environmental forces 
(NE) and NE granule 
distribution 
19 Noninvasive direct measure- Human Flow distribution Application of ultrasonics to flow Gated Doppler velocity sensor


ment of CV dynamics Flow direction sensing Battery-operated echocardiograph


Flow velocity Ultrasonic flow sensor (directional)


Cardiac structures


20 Fluoroscopic cardiac imaging Human Cardiac size during X-ray fluoroscopic techniques with Low-dose x-ray system, fluoroscopic


for heart size dynamic states stress testing Centrifuge, human


21 Obtain inflight data on Human Heart size and shape Roentgen video densitometry Inflight x-ray system

0 size and shape of various changes - Computer-assisted data analysis


heart chambers or circulation Circulation in heart 3D reconstruction of heart


Coronary Blood vessels
 

22 Develop implantable CV Animals ECG Animal invasive studies using RF inductive-coupled links


bioinstrumentation Flow implantable transducers Transducers for ECG, flow, and


SPr..u r pressure


0 	 23. Small primate prototype CV Animals ECG Environmental testing of the rhesus Transducers for ECG and body


flight experiment Temperature monkey with implanted transducers temperature


and various power sources 
t 24. 	 Minimization of orthostatic Human Stimulation Apply vibration and monitor with Vibration facility


intolerances via imposed accelerometer Externally applied vibration
 

dynamic acceleration transducers


25. 	 Math modeling of CV factors N/A Pressures Math modeling LBNP


dependent on gravitational Flows
Stimulus


26. Develop biotelemetry packages Animals Inputs 	 Application of advanced ICs Biotelemetry packages


(primates Body temperature With batteries


and ECG With inductive power sources


rodents) EEG


Pressure


Muscular activity


pH and p02 of blood


27. 	 Develop multichannel Animal Inputs 	 Implant into artificial hearts in Multichannel telemetry system


telemetry system EGG calves and sheep at University


Temperature of Utah


Pressure


TABLE XXIV.- CANDIDATE INSTRUMENTATION


REQUIRING FURTHER REFINEMENT


1. Photoplethysmograph


2. Improved LBNP


3. Catheters for animals


4. Echocardiograph


5. Radioisotope equipment


6. Multisensor transducer for wall motion


7. Vectorcardiograph


8. Limb plethysmograph


9. Scanning echo device


10. Implantable flow transducers


11. Biotelemetry systems, implantable and backpacks


12. Data compression electronics


13. Radiotelemetry stimulators


14. Low-dose X-ray system


15. RF inductive power sources


16. Temperature transducers, implantable


17. Pressure transducers, implantable


18. ECG "dry" leads


19. Vibration stimulators


20. Multichannel telemetry systems


21. Ergometer


Noninvasive


Echocardiography.- A major direction for ultrasound usage in


space medicine is the further development of linear and two-dimen­

sional transducer arrays for three-dimensional imaging along with


the concurrent development of improved display techniques. Heart


size and other ventricular function measurements are essential.


Dietary and exercise studies.- Techniques must be developed


to prevent or compensate for space-flight cardiovascular decon­

ditioning. Improved dietary and exercise programs should be


thoroughly evaluated during the bed-rest studies as a function of


historical observations.
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Plethysmography.- A reliable plethysmograph is required for


blood flow and volume determination. The Skylab unit does pro­

vide a volume estimate via a capacitive technique; however, it


is not easy to use due to postflight calibration requirements.


If a microprocessor were used'in conjunction with the plethysmo­

graph, this would enable a real-time readout. This same micro­

processor should be used to control the LBNP chamber pressures


for maximum utility. Conversely, electrical impedance tech­

niques are limited due to resistivity problems and are not recom­

mended. The obvious advantage of the plethysmograph is that


differential changkcan be related to an absolute volume.


Image analysis techniques.- Ultrastructure analysis of cellular


structure as a result of cardiovascular deconditioning is recom­

mended as a means of increasing resolution of electron micro­

graphs. The image enhancement facility at JPL constitutes a


unique tool for this activity.


Lower body negative pressure system.- The LBNP has proved its


utility in Skylab and in recent bed-rest studies wherein increased


heart rate during LBNP tests were generally shown to be the best


single index in the assessment of orthostatic tolerance. By com­

bining the circulatory effects of LBNP with echocardiographic


analysis of ventricular volume,, one would have a unique noninvasive


method for assessment of the left ventricular function as well as


for stress testing of the cardiovascular system in general. It


is also recommended that control of chamber pressure be'automated.


Roentgen videodensitometry.- Techniques for providing dynamic


and stop-action, three-dimensional reconstructions of any part of


the body are currently under development, e.g., the dynamic spatial


reconstructor being developed at the May Foundation in Rochester,


Minnesota, under the direction of Earl Wood (see Preston 1976).


It is designed to sense and digitize at 60 frames per second 28


simultaneous planar projections that will be created by 28 video­

scanned, pulse X-ray source-detector assemblies arranged in a r


semicircle. Computerized tomography in which data gathered from


an X-ray scanner are fed into a computer to produce cross-sectional


images of the human body certainly should be considered for future


space flight as well as for preflight and postflight observation


of the body. Development work in the areas of data storage and


analysis, increase in computational speed, and hardware size reduc­

tion shouldcontinue for the Shuttle application.
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Invasive Instrumentation


The chronic invasive instrumentation of animals has been facil­

itated by the advent of small reliable transducers. The small


physical size and potential for-long-term stability of presently


available transducers permits rather extensive instrumentation of


even small animals (cats, rats). The low expected mortality


should permit animals to serve as their own controls, and rather


complex protocols should be possible. Some development work


beyond that already accomplished (e.g., by Hanley, Hartley, and


others) will be necessary to adapt the instrumentation to space


experiments.


We recommend that emphasis be placed on the necessary further


development of catheter tip ultrasonic flowmeters, implantable


pressure transducers, and a whole range of implantable ultrasonic


blood velocity and organ morphology measuring devices.


Integrated Cardiovascular Measurement System


To arrive at an integrated cardiovascular measurement system,


it is essential that (1) the necessary observables be defined,


(2) the evolutionary instrument selection procedure be well estab­

lished with appropriate alternatives, and (3) the environmental


and experimental criteria be defined. More important perhaps is


the necessity for a logical set of experiments that can best


characterize the optimal approach to the determination of cardio­

vascular deconditioning processes. This experiment set is being


solicited by NASA, both internally and from the biomedical com­

munity at large. Unfortunately, such an experiment set was not


available for this study. Nevertheless, the results obtained


from previous space flights and bed-rest studies are indicative


of what further knowledge pertaining to cardiovascular decondi­

tioning is required. Figure 15 illustrates a logical approach


toward defining an integrated cardiovascular measurement system.


Iterative loops will be required to select a near-optimal


set of instrumentation tailored to the required observables.


Consideration must also be given to common equipment usage. A


representative integrated biomedical measurement system for a


Spacelab mission is as shown in table XXV wherein commonality of


hardware is indicated. It should also be pointed out that the


physical characteristics and mission objectives of a particular


Skylab life sciences laboratory will influence instrumentation


configurations and it is fully expected that the cardiovascular


instrumentation configurations will be evolutibnary.
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Figure 15.- Development of an integrated cardiovascular measurement system.


TABLE XXV.- EXAMPLE OF AN INTEGRATED BIOMEDICAL MEASUREMENT SYSTEM 
Required Hardware 
U0 
WO0N 
O 
4)W 
H). 0 
04 
0 
c 
C) 4) JJ 
Cd W H. 0 0 H)4 
H4 N i dM 0 kU Po000 
Experiment Objectives and Observations H w 0 4 0 di 
Cardiovascular Altered vascular flow/volume/pressure relationships. X X X X X 
Internal blood flows, pressures, urine and blood 
collection, freeze and store; food and fluid in­
take, biochemical analysis. 
ECG/pulse, Doppler flowmeter. X X 
Demonstrate myocardial degeneration resulting from X X 
Musculoskeletal Absolute catabolic effects of zero-g. Food and fluid X 
intake, histological preparations of bone, bone 
marrow, muscle. 
Hematology Invasive studies -­ measure total blood volume, red 
blood cell mass, blood 02 tension; obtain reticulo- X X X I 
C cyte counts, collect, prepare and store blood 
o samples 
0 
Biochemical Reactions Fluid and electrolyte balance, Ca regulation, X X X I 
adrenal function; urine collection, preserva­
tion and analysis; onboard and gound analysis. 
Pulmonary Respiratory gas analysis. X X 
APPENDIX


PRELIMINARY CORE PRIORITY LIST


Accelerometer


Accelerometer, coupler


Adapters, TV microscope


Analyzer, general spectrophotometer


Atmospheric sampling manifold


Auto potenelectrolyte analyzer
 

Badges, radiation


Bags, plastic
 

Bicycle ergometer


Blood pressure system with cuff (noninvasive)


Body mass measuring device


Breathing regulator pressure demand


Calculator, portable


Camera controller


Camera mounts


Camera, cine 
Camera, polaroid


Camera, video, B/W


Camera, video, color


Camera, 35 mm


Can crusher (Skylab) 
Cardiopul analyzer system


Cardiotachometer


Cell counter


Centrifuge, table top


Centrifuge, reference high-speed,


Chemical storage cabinet
 

Chemical containers


Chemical-radioactive, container


Cleaner, handiwipes


Cleaner, vacuum
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Cleaner, hand washer


Commutator, gas manifold


Compactor, waste solids


Computer, digital


Cbonfter, colony (manual)


Coupler, phono/vicrocardiogram


Coupler, vectorcardiogram


Coupler, gas-liquid flowmeter


Coupler, impedance pneumograph


Crew mobility aids


Crew restraints


Data management system buses


Digital voltmeter


Display - numeric


Display - keyboard, portable


DMS, control station


DMS, instrumentation modified


DMS, plotter/printer


Equipment restraints


Exercise equipment (Skylab)


ECG coupler


EEG coupler-

Film


Filters, video (Skylab)


Flowmeter, breathing gas


Flowmeters, general-gases and liquid


Fluid handling kit


Freezer


Freezer, cryogenic


Freezer, low temperature (holding)


Gas analyzer mass spectrometer
 

Gas chromatograph


Gas supplies


General photometer
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Holding unit, cells and tissues


Holding unit, invertebrate


Holding unit, plants


Holding unit, primates


Holding unit, small vertebrates


Incubator


Infrared gas analyzer


Kit, cleanup


Kit, general inventory


Kit, general tool


Kit, maintenance


Kit, stationary


Kit, tool - insection manipulator


Kit, urine acquisition


Lamp, portable high-intensity photo


Life sciences bioresearch center


Liquid tank


Log books


Lyophilizer


Mask, pressure breathing


Mass measuring device (macro)


Mass measuring device (micro)


Meter, pH


Meter, total solids refraction


Microprocessor


Microscope, dissecting


Microscope, comp-binocular


Microtome


Miniature fast analyzer


Mixer, temperature-controlled


Monitor, video


Oscilloscope


Paper, recording


Photocell (coupler)
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Photocells


Plethysmograph, limb


Power supply and conditioning


Radiation counter biochemical sampler


Radiation detector, general


Recorder, multichannel biomedical


Refrigerator


Rotating litter chair


Signal conditioning rack


Small recorder, voice


Sound level meter


Staining system


Stop watch


Storage, film


Storage, general


Tape, video


Tape, voice recorder


Temperature block


Thermocouple coupler


Thermocouples


Timer, events


Tissue homogenizer


Transducer, plethysmograph


Trash can


Video ID date-time system


Video tape recorder


Volumetric measuring (liquid) kit


Vomitus bag & holder


Waste storage bag


Waste storage device


Waste storage, radiological and biological


Workbench, crew work station (ESRO)


Workbench, general experiments


Workbench, life support and protective system
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Workbench modification, debris containment shroud


Workbench modification, environmental shroud
 

Workbench modification, surface airflow


Workbench, surgical


GENERAL INVENTORY KIT 
Animal physiology kit 
Chemical analysis kit 
Hematology kit
 

Histology kit
 

Linear measurement kit


Microdissection kit


Microbiology kit
 

Organism holding kit


Physiology kit


Plant toools kit


Veterinary kit


Physical examining kit


Insect manipulation tool kit
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